<html><head><meta http-equiv=Content-Type content="text/html; charset=windows-1252"><meta name=Generator content="Microsoft Word 10 (filtered)"><TITLE>INQUIRY UNDER THE FATAL ACCIDENTS AND INQUIRIES (SCOTLAND) ACT 1976 INTO THE SUDDEN DEATH OF DANIELLE WELSH v. , 02 February 2011, Sheriff A.M. Cubie</TITLE> <style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Palatino Linotype";
	panose-1:2 4 5 2 5 5 5 3 3 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0pt;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:Tahoma;
	color:windowtext;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0pt;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:Tahoma;
	color:windowtext;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin-right:0pt;
	margin-left:0pt;
	font-size:12.0pt;
	font-family:"Times New Roman";
	color:windowtext;}
a:link, span.MsoHyperlink
	{font-family:"Times New Roman";
	color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;}
p
	{margin-right:0pt;
	margin-bottom:3.75pt;
	margin-left:0pt;
	font-size:12.0pt;
	font-family:"Times New Roman";
	color:black;}
p.DefaultText, li.DefaultText, div.DefaultText
	{margin:0pt;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman";
	color:windowtext;}
p.ListParagraph, li.ListParagraph, div.ListParagraph
	{margin-top:0pt;
	margin-right:0pt;
	margin-bottom:0pt;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman";
	color:windowtext;}
p.ListParagraphCxSpFirst, li.ListParagraphCxSpFirst, div.ListParagraphCxSpFirst
	{margin-top:0pt;
	margin-right:0pt;
	margin-bottom:0pt;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman";
	color:windowtext;}
p.ListParagraphCxSpMiddle, li.ListParagraphCxSpMiddle, div.ListParagraphCxSpMiddle
	{margin-top:0pt;
	margin-right:0pt;
	margin-bottom:0pt;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman";
	color:windowtext;}
p.ListParagraphCxSpLast, li.ListParagraphCxSpLast, div.ListParagraphCxSpLast
	{margin-top:0pt;
	margin-right:0pt;
	margin-bottom:0pt;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman";
	color:windowtext;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;}
div.Section1
	{page:Section1;}
 /* List Definitions */
 ol
	{margin-bottom:0pt;}
ul
	{margin-bottom:0pt;}
-->
</style> </head><body lang=EN-US link=blue vlink=purple><div class=Section1><p class=MsoNormal align=right style='text-align:right'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>2011 FAI 7</span></b></p><p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>SHERIFFDOM OF GLASGOW </span></b><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>AND</span></b><b><span lang=EN-GB style='font-family:"Palatino Linotype"'> STRATHKELVIN</span></b></p><p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p class=MsoNormal align=center style='text-align:center'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>DETERMINATION INTO THE CAUSES OF DEATH OF DANIELLE WELSH</span></b></p><p class=MsoNormal><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p class=MsoNormal><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Determination pages 1- 33</span></p><p class=MsoNormal><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Appendix 1- Witnesses to the enquiry</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Appendix 2-Glossary of selected medical and technical terms</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Appendix 3-Excerpts from the written submissions for GGHB </span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Appendix 4-Excerpts from the written submissions for Dr Das and Dr Fraser</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Appendix 5- Steps taken by the Health board after the fatality</span></p><p class=MsoNormal><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p class=MsoNormal><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Representation at the Enquiry</span></b></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>For the Crown</span></b><span lang=EN-GB style='font-family:"Palatino Linotype"'>; Ms Gail Adair,&nbsp;Procurator Fiscal Depute,&nbsp;Procurator Fiscal's Office, </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>Glasgow</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>.</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Contact telephone number; 08445612220</span></p><p class=MsoNormal><span style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>For the Family of Danielle Welsh</span></b><span lang=EN-GB style='font-family:
"Palatino Linotype"'>; Mr David Hunter, Solicitor of Messrs Hughes Dowdall Solicitors </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>Glasgow</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> </span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Contact telephone number; 0141 240 7020</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>For Greater Glasgow Health Board</span></b><span lang=EN-GB style='font-family:
"Palatino Linotype"'>; Mr David Stephenson QC, instructed by the National Health Service Scotland Central Legal Office.</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Contact telephone number; 0131 275 7800</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;&nbsp;</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>For Dr Das and Dr Fraser</span></b><span lang=EN-GB style='font-family:"Palatino Linotype"'>; Ms Laura Donald, Solicitor Advocate of Messrs Brechin Tindall Oatts, Solicitors, Edinburgh </span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Contact telephone number; 0131 220 2777</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><span style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Determination as to the causes of death of Danielle Welsh.</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
  "Palatino Linotype"'>Glasgow</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>the 2nd February 2011</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Having resumed consideration of the cause I determine as follows</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><b><u><span style='font-family:"Palatino Linotype"'>Determination</span></u></b></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span style='font-family:"Palatino Linotype"'>I find and determine in terms of the Fatal Accidents and Sudden Deaths Inquiry (Scotland) Act 1976 as follows:- </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span style='font-family:"Palatino Linotype"'>In terms of Section 6(1)(a) that Danielle Welsh died at The Royal Infirmary of Edinburgh at </span><span style='font-family:"Palatino Linotype"'>10.25am</span><span style='font-family:"Palatino Linotype"'> on </span><span style='font-family:"Palatino Linotype"'>the 24<sup>th</sup> June 2008</span><span style='font-family:"Palatino Linotype"'>.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span style='font-family:"Palatino Linotype"'>In terms of Section (1)(b) that the cause of her death was</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Liver failure due to </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Paracetamol toxicity due to </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Iatrogenic paracetamol overdose.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=ListParagraphCxSpFirst style='margin-left:0pt;line-height:150%;
text-autospace:none'><span style='font-size:12.0pt;line-height:150%;font-family:
"Palatino Linotype"'>In terms of Section 6(1)(c) I find that the reasonable precautions whereby her death might have been avoided were as follows:-</span><span lang=EN-GB style='font-size:12.0pt;line-height:150%;font-family:"Palatino Linotype"'> .</span></p><p class=ListParagraphCxSpMiddle style='margin-left:28.35pt;line-height:150%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:150%;
font-family:"Palatino Linotype"'>If Dr Das had checked the British National Formulary before prescribing intravenous paracetamol for Danielle on the evening of </span><span lang=EN-GB style='font-size:12.0pt;line-height:150%;
 font-family:"Palatino Linotype"'>17 June 2008</span><span lang=EN-GB style='font-size:12.0pt;line-height:150%;font-family:"Palatino Linotype"'>. </span></p><p class=ListParagraphCxSpMiddle style='margin-left:28.35pt;line-height:150%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:150%;
font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=ListParagraphCxSpMiddle style='margin-left:28.35pt;line-height:150%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:150%;
font-family:"Palatino Linotype"'>If the nursing staff who administered intravenous paracetamol to Danielle between 17 and 20 June had checked that they knew the normal dosage of the intravenous paracetamol to be administered by them having regard to Danielle's weight</span></p><p class=ListParagraphCxSpMiddle style='margin-left:28.35pt;line-height:150%;
text-autospace:none'><b><span lang=EN-GB style='font-size:12.0pt;line-height:
150%;font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p class=ListParagraphCxSpLast style='margin-left:28.35pt;line-height:150%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:150%;
font-family:"Palatino Linotype"'>If the Pharmacist Lesley Murray had checked the British National Formulary in respect of intravenous paracetamol when reviewing Danielle's drug Kardex in Ward 67. </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span style='font-family:"Palatino Linotype"'>In terms of Section 6(1)(d) from the evidence adduced, I find that there were no defects in the system of working which contributed to the death:</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span style='font-family:"Palatino Linotype"'>In terms of Section 6(1)(e), from the evidence adduced I find that there was at the time of the death, a prevailing culture of assumed familiarity with the administration of intravenous paracetamol, a familiarity derived from the common use of oral paracetamol. That assumed familiarity was misplaced.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[1] Representation</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>The crown was represented by Miss Adair, Procurator Fiscal Depute; the family were represented by Mr Hunter, solicitor, Glasgow, Doctors Das and Fraser by Miss Donald, solicitor, Edinburgh, and the GGHB by Mr Stephenson QC. The inquiry was admirably focused and I am grateful to those representatives for their various contributions</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[2] I wish to pay tribute to the family; it was clear to all that Danielle's tragic death has left a huge hole in the Welsh family; photographs lodged made clear that she was a lively and active participant in all family activities. Her death was plainly devastating. The family attended every day and conducted themselves throughout with composure, patience, and dignity despite some passages of evidence which must have been very difficult for them to hear. I express the condolences of the court to Danielle's family.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Purpose of a fatal accident enquiry<b> </b></span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>[3] Legal Framework</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>The purpose of the Inquiry in terms of the Fatal Accident and Sudden Deaths Inquiry (</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>Scotland</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>) Act 1976 is for the Sheriff to make a determination setting out the following circumstances of the death, so far as they have been established to his satisfaction- </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='margin-left:56.7pt;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>(a) Where and when the death and any accident resulting in the death took place; </span></p><p class=MsoNormal style='margin-left:56.7pt;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>(b) The cause or causes of such death and any accident resulting in the death; </span></p><p class=MsoNormal style='margin-left:56.7pt;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>(c) The reasonable precautions, if any, whereby the death and any accident resulting in the death may have been avoided; </span></p><p class=MsoNormal style='margin-left:56.7pt;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>(d) the defects, if any, in the system of working which contributed to the death or any accident resulting in the death; </span></p><p class=MsoNormal style='margin-left:56.7pt;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>(e) any other facts which are relevant to the circumstances of the death (all in terms of Section 6(1) of the Act)</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[4] The Court proceeds on the basis of evidence placed before it and although described as an Inquiry, the Sheriff's powers generally do not go beyond making a determination in relation to the circumstances established to his satisfaction by evidence following upon investigation by the Procurator Fiscal and any other party if so advised.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[5] This inquiry is not the proper forum for determination of civil liability or of negligence and any findings in any such inquiry should avoid connotations of negligence (See <i>Black -v- Scott 1990 </i></span><i><span lang=EN-GB style='font-family:"Palatino Linotype"'>SLT</span></i><i><span lang=EN-GB style='font-family:"Palatino Linotype"'> 612</span></i><span lang=EN-GB style='font-family:"Palatino Linotype"'> and <i>Dekker 2000 SCLR 1087</i>). </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=DefaultText style='text-align:justify;line-height:150%'><span style='font-family:"Palatino Linotype"'>[6] Mr Stephenson's written submission included a very helpful passage on the powers and limitations on these powers which the sheriff exercises in a Fatal Accident Inquiry and which makes reference to the <i>Report of Findings of the review of Fatal Accident Inquiries</i>, an independent enquiry by Lord Cullen published in November 2009.</span></p><p class=DefaultText style='text-align:justify;line-height:150%'><span style='font-family:"Palatino Linotype"'></span></p><p class=DefaultText style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[7] Lord Cullen considered the role of the sheriff in his final Report. With particular reference to recommendations he expressed the following views:-</span></p><p class=DefaultText style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='margin-left:28.35pt;text-autospace:none'><span lang=EN-GB style='font-family:"Palatino Linotype"'>3.28 Taking these questions in turn, it is, in my view, unsatisfactory that there is uncertainty as to the power of the sheriff to make recommendation arising out of his or her findings, or as to the potential scope for such recommendations. I am in no doubt that the sheriff should be able to make recommendations directly related to the circumstances of the individual death. At the same time I consider that there is considerable force in the arguments against the sheriff making recommendations of general application, to which I have referred...</span></p><p class=MsoNormal style='margin-left:28.35pt;text-autospace:none'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='margin-left:28.35pt'><span lang=EN-GB style='font-family:"Palatino Linotype"'>3.29 It would be inappropriate, in my view, for an FAI to be treated as if it were a public enquiry taking a nationwide approach and calling for far greater resources. For a sheriff to over-reach what could be supported from his evidence would detract from the respect which his or her recommendations deserve</span></p><p class=MsoNormal style='line-height:150%;text-autospace:none'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=DefaultText style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[8] It was submitted for the Health Board that the practice of making recommendations, while it is an established one, may in fact be unnecessary in the light of the statutory findings that the Sheriff is required to make. It was submitted that any recommendations should be recommendations directly related to the particular circumstances of the case and any such recommendations should recognise the limitations of the procedure and the evidence heard and avoid "over-reach". I agree with that general approach. </span></p><p class=DefaultText style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=DefaultText style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[9] Accordingly in framing this determination I have in mind the restrictions on the enquiry and the powers to make recommendations.</span></p><p class=DefaultText style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[10] Similarly, having regard to the submissions of the Health Board I adopt Sheriff Kearney's observations </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>in his determination in relation to the death of James McAlpine, issued on 17 in January 1986, and referred to at paragraph 8-99 of the 3<sup>rd</sup> edition of <i>Sudden Deaths and Fatal Accident Inquiries </i>by Ian Carmichael. Sheriff Kearney observed:-</span></p><p class=MsoNormal style='margin-left:36.0pt'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&quot;In deciding whether to make any determination (under section 6(1)(d)) as to the defects if any in any system of working which contributed to the death or any accident resulting in the death, the court must, as a precondition to making any such recommendation, be satisfied that the defect in question did in fact cause or contribute to the death. The standard of proof and rules of evidence (apart from the consideration that evidence did not require to be corroborated) is that applicable in civil business (1976 Act section 4(7)) and accordingly the standard of proof is that of the balance of probabilities.&quot;</span></p><p class=MsoNormal style='margin-left:36.0pt'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&quot;In relation to making a finding as to the reasonable precautions, if any, whereby the death and any accident resulting in the death might have been avoided (section 6(1)(c)) it is clearly not necessary for the court to be satisfied that the proposed precaution would in fact have avoided the accident or the death, only that it might have done, but the court must, as well as being satisfied that the precaution might have prevented the accident or death, be satisfied that the precaution was a reasonable one.&quot;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[11] Sheriff Kearney went on to say:-</span></p><p class=MsoNormal style='margin-left:36.0pt'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&quot;The phrase 'might have been avoided' is a wide one which has not, so far as I am aware, been made the subject of judicial interpretation. It means less than 'would, on the probabilities have been avoided' and rather directs one's mind in the direction of the lively possibilities.&quot;</span></p><p class=MsoNormal style='margin-left:36.0pt;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[12] The Evidence</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Evidence in this case was heard over a total of twelve days. The matter was protracted to some extent because the health board challenged the conclusions of the post mortem, whereby Danielle had died as a result of paracetamol toxicity.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[13] A different diagnosis was contained in Professor Pounder's report, that of Reye's syndrome. However in the event, the health board accepted that the appropriate diagnoses was that of Dr. MacAdam supported by Professor Burt and Dr Dillon, to the effect that Danielle died of liver failure due to paracetamol toxicity.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[14] The challenge made by the Health Board to the evidence led by the Crown was perfectly intelligible in the context of Professor Pounder's report, as was their decision not to call Professor Pounder in the context of the evidence as it unfolded before the inquiry</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[15] Accordingly the inquiry concentrates on other aspects of Danielle's care and whether there were any precautions, or defects, or other factors and whether there are any recommendations arising of more general application.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[16] I found the following facts established.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Background</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[i] Danielle was born on </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>the 5<sup>th</sup> of June 1989</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>. She had an undefined condition; her sister Catherine is the only other diagnosed case in </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>Scotland</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>. This condition gave rise to spondyloepiphyseal dysplasia, short stature, mild but longstanding learning difficulties, problems with hearing and chronic pain particularly in the limbs and joints. Danielle had for some time been under the care of inter alia Dr John Currie at the </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>Royal</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>Hospital</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> for Sick children, Yorkhill. He is a consultant paediatric anaesthetist with an interest in pain relief. If the normal analgesics did not assist, then Danielle would see him. At June 2008 she weighed 35 kilogrammes.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[ii] Given Danielle's age, the management of her case was in the process of being transferred from </span><span lang=EN-GB style='font-family:
  "Palatino Linotype"'>Royal</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>Hospital</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> for Sick Children at Yorkhill to the Southern General Hospital (SGH) . She was waiting to be seen by the Pain Clinic at SGH</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[iii] At June 2008 Danielle was on a regular regime of prescribed medicines which included Tramadol and paracetamol. These were taken orally, although on occasion Danielle did not like taking pills.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=ListParagraphCxSpFirst style='margin-left:0pt;line-height:150%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:150%;
font-family:"Palatino Linotype"'>[iv] Paracetamol is usually supplied in the form of tablets (oral paracetamol). It can also be administered per rectum or intravenously. The standard adult therapeutic dose for oral paracetamol is 1g four times daily. This is also the standard therapeutic dose in children from the age of 12. Medical professionals including all doctors, pharmacists and nurses are generally familiar with the use of oral paracetamol, and aware of the standard dose..</span></p><p class=ListParagraphCxSpMiddle style='margin-left:0pt;line-height:150%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:150%;
font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=ListParagraphCxSpMiddle style='margin-left:0pt;line-height:150%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:150%;
font-family:"Palatino Linotype"'>[v] Whereas paracetamol given orally has been in widely used for a period in excess of fifty years, intravenous paracetamol has been a more recent addition to the range of analgesics available to the medical profession. It had begun to be used in post operative care but the ease of use, the lack of side effects and the apparent familiarity of the drug meant that its use became more widespread. The sole manufacturer is Bristol-Myers Squibb Pharmaceuticals Limited (Bristol-Myers) who market their product under the name Perfalgan. The intravenous paracetamol given to Danielle was Perfalgan. </span></p><p class=ListParagraphCxSpMiddle style='margin-left:0pt;line-height:150%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:150%;
font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=ListParagraphCxSpLast style='margin-left:0pt;line-height:150%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:150%;
font-family:"Palatino Linotype"'>[vi] </span><span lang=EN-GB style='font-size:
12.0pt;line-height:150%;font-family:"Palatino Linotype"'>Paracetamol in excess can be toxic to the liver and may result in acute liver failure leading to death. Voluntary drug overdoses often involve ingestion of paracetamol. The clinical manifestation of paracetamol toxicity is delayed and may only manifest up to 96 hours after ingestion. Again doctors, pharmacists and nurses are likely to know this. This has to be seen in context. In day to day hospital practice, drugs that could be toxic in overdose are used, many of which are as or more intrinsically dangerous than paracetamol. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[vii] The consequences of an overdose of paracetamol are as follows; in the standard dose of paracetamol, approximately 90% is conjugated with Glucuronides and other molecules suitable for renal excretion. The remaining 10% or so is metabolised by Cythchrome P450 enzyme 2E1 into a toxic metabolite called </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>NAP</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> QI. This is normally rapidly conjugated with Glutathine and is then neutralised and safe for excretion. Glutathine stores in the liver are relatively short-lived requiring regular supplementation by feeding. As the amount of Paracetamiol in the blood increases, the metabolism by the P450 2E1 pathway increases exponentially as the Glucoronidation pathway has a fixed ceiling; every increase above the standard dose gives rise to a disproportionately toxic effect</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[viii] Paracetamol is dealt with in the Clinical Handbook which was in use at the time as follows:-</span></p><p class=MsoNormal style='margin-left:28.35pt;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>"Paracetamol is an effective analgesic for mild to moderate pain and improves the effect of other analgesics in the treatment of moderate and severe pain...All patients should be offered it regularly to a maximum dose (1g four times daily) by the oral or rectal route, prescribing it in the regular prescriptions section of the Prescription form." There is no mention of an intravenous prescription.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'></span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[ix] The intravenous dose of paracetamol is dealt with in the British National Formulary No 55 ("BNF") as follows, inter alia, at page 227:-</span></p><p class=MsoNormal style='margin-left:28.35pt;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>"By intravenous infusion over 15 minutes ADULT and CHILD over 50 kg, 1g every 4-6 hours, max 4g daily; ADULT and child 10-50 kg, 15mg/kg every 4-6 hours, max 60mg/kg daily".</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[x] The perfalgan vial used by the hospital has a label which, after listing the ingredients, says the following:</span></p><p class=MsoNormal style='margin-left:28.35pt;line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>"See enclosed leaflet</span></b></p><p class=MsoNormal style='margin-left:28.35pt;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>Do not store above 30°C</span></p><p class=MsoNormal style='margin-left:28.35pt;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>Do not refrigerate or freeze</span></p><p class=MsoNormal style='margin-left:28.35pt;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>Keep out of the reach and sight of children</span></p><p class=MsoNormal style='margin-left:28.35pt;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>Restricted to adults and children weighing more than 33kg</span></p><p class=MsoNormal style='margin-left:28.35pt;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>Please see leaflet for other information."</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xi] The leaflet referred to will rarely if ever be with the individual vial. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xii] At the time of Danielle's admission, all staff who dealt with her considered that they were familiar with paracetamol. The general level of knowledge was to the effect that there was no distinction between the two modes of administration i.e. oral and intravenous in terms of the amount prescribed. There was no widespread awareness or knowledge of the distinction between Intravenous and oral administration of paracetamol, and the consequent difference in effect. Oral administration of medicine is preferable to intravenous administration. In the ordinary course, any medicine which can be administered orally will be preferred and the oral route resumed as soon as practicable</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xiii] Against that background Danielle found herself in the Southern General hospital.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xiv] Timeline</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>15<sup>th</sup> June 2008</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Danielle was increasingly confused argumentative and aggressive. This was out of character. She complained of feeling unwell. Her parents were sufficiently concerned to take her to the SGH. They presented at about 23.23. She was seen by a triage nurse at the Accident and Emergency Department and then by the locum registrar, Dr Bardham. Danielle was referred to the on call Specialist registrar. She was found to be responsive but very anxious, with confused speech. Her temperature and blood pressure were normal. A number of laboratory tests were carried out, disclosing raised white cell count which might point to infection. The initial concern was encephalitis or meningitis. A brain scan was arranged with a view to a lumbar puncture if that was negative.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xv] </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>16<sup>th</sup> June 2008</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>The CT scan was normal. Danielle was seen by Dr Wallace again about 03.45. A lumbar puncture was attempted but could not be effected. An </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>MRI</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> brain scan was considered but Danielle's condition, where she continued to be agitated, precluded that as the patient requires to be still. The presumptive diagnosis was addressed by the administration of anti-viral and antibiotic drugs as shown by the Kardex at p 51 A B &amp;C </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xvi] Danielle's height and weight were not entered on the Kardex, although there is a space for weight; (P51) However, in gremio of the hospital notes, Dr Wallace recorded Danielle's weight and prescribed the drugs "according to weight/paediatric doses." Danielle was also prescribed 1g paracetamol "as required". The route of prescription was given as "IV/PO", meaning either intravenously or orally. The prescriber of that drug cannot be identified. It must have been prescribed before </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>6.45am</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>. This appears at p 56 of the Kardex. The prescriber appears to have equiparated the oral and intravenous doses of paracetamol.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xvii] At </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>10.30 am</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> Danielle was seen in ward 20 by Dr Semple.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Danielle was transferred to Ward 21 where she remained until the 19<sup>th</sup> June</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>The "as required" paracetamol was stopped during the course of the 16<sup>th</sup> June.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xviii] </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>17<sup>th</sup> June 2008</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Danielle remained on Ward 21; she was seen by a number of junior doctors. That ward was normally the responsibility of Lorraine Perry, a clinical Pharmacist; she was not on duty and her responsibilities fell upon Saima Afzal, who reviewed Danielle's Kardex. She was aware, (although she could not remember why) that Danielle's weight was 35kg and consulted both the adult and paediatric BNF to confirm that the antibiotic prescription was appropriate. Danielle was noted to be vomiting by the evening. Oral administration of drugs was accordingly more difficult. She continued to be in pain. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xix] Dr Das was on duty. She was then a foundation year one doctor . This was some time around </span><span lang=EN-GB style='font-family:
 "Palatino Linotype"'>10.00pm</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>. She was asked, probably by way of a post-it note on the Kardex, to prescribe pain relief and anti-emetic drugs. She had had no previous dealings with Danielle; she did not know her weight. She proceeded to prescribe on the basis that Danielle was an adult. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xx] She had not used intravenous paracetamol before; her decision was informed by a number of factors as follows:-</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>The patient had previously had oral paracetamol; </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>There was a previous prescription for intravenous paracetamol (albeit as an alternative to Oral; </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>She regarded herself as familiar with paracetamol (albeit not intravenous administration); </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>She recalled that it was a nursing suggestion; </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>She was prescribing in an adult hospital; </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>The practice was to revert to oral administration at the earliest opportunity; any prescription would be subject to review.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>She did not see Danielle; she did not know her weight; she did not check the BNF. She did not know the dosage. She did not know that it was weight dependent. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>In the event, the dosage prescribed, 1g four times daily, was in excess of the appropriate dosage for someone of Danielle's weight. She should have received 525mg per dosage.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xxi] Danielle received 2 doses of the prescribed IV paracetamol in the evening. An </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>MRI</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> scan was attempted but abandoned due to significant agitation. It was determined that she should have an </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>MRI</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> scan and a lumbar puncture in the Institute of Neurological Sciences at ward 67 SGH.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xxii] </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>18<sup>th</sup> June 2008</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Danielle was admitted to ward 67 for the administration of the </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>MRI</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> and lumbar puncture under general anaesthetic, as well as for general assessment. This transfer was necessary as these procedures could not be undertaken in any other ward. The intravenous administration of paracetamol continued.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xxiii] </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>19<sup>th</sup> June 2008</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Danielle remained in ward 67; for the purposes of the enquiry the care was not noteworthy. A lumbar puncture was performed and was normal. The intravenous paracetamol continued. An </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>MRI</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> scan was normal. Her white cell count was still high, but the medical staff were able to discount any neurological disease. The diagnosis otherwise was still unclear. Further tests were undertaken.Danielle's Kardex was reviewed there by Pharmacist Lesley Murray. She may not have seen Danielle in person. She did not alter the prescription. She did not know that the intravenous and oral dosages of intravenous paracetamol were different. She assumed that they were the same. She did not check. The need for intravenous rather than oral painkillers continued with Danielle still on a drip; she was prescribed a second, additional, anti-emetic for nausea in the course of the evening, showing that she continued to be nauseous, and undermining the utility of oral administration of paracetamol. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xxiv] </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>20<sup>th</sup> June 2008</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Danielle was still agitated. Danielle was transferred back to ward 25; this was a different medical ward. By this time the combination of infection indicators and the identification of what appeared to be "crackles" on the lungs gave rise to a possible diagnosis of atypical pneumonia. As a result of this, her prescription of Acyclovir was stopped as this was an antiviral drug no longer felt to be addressing the condition.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xxv] </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>21<sup>st</sup> June 2008</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>There are no medical notes or nursing notes for the 21<sup>st</sup> June The clinical notes go from the 20<sup>th</sup> June to 22<sup>nd</sup>. No tests appear to have been undertaken</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xxvi] </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>22<sup>nd</sup> June 2008</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Danielle continued to be treated for atypical pneumonia; there seemed to be an improvement noted to her demeanour. Her condition initially caused concern because her SEWS score was 4. Blood tests were taken and showed grossly abnormal Liver Function Tests. She was referred to a consultant who at 23.25 referred to the liver unit at Royal Infirmary of Edinburgh (RIE). There was considerable concern about Danielle's fitness for transfer.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xxvii] </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>23<sup>rd</sup> June 2008</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>At 01.30 Danielle was transferred by ambulance to Surgical </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>ITU</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> with acutely deranged Liver Function tests with coagulopathy and raised paracetamol levels. Danielle was in a critical condition so was intubated and ventilated to provide a degree of stability for the transfer, arriving at </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>03.45 am</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>. She was stabilised .She was considered for Transplant but having regard to the appropriate criteria, she was considered to be unsuitable. She was considered to be likely to survive. Although ill, the prognosis was reasonable.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[xxviii] </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>24<sup>th</sup> June 2008</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Danielle suffered a cardiac arrest. She was subject to intensive CPR for a period of 35 minutes or so; she appeared to recover but was very unwell. She then suffered another heart attack and was pronounced dead at </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>10.25 am</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>It was recorded that Danielle died of liver failure due to paracetamol toxicity due to paracetamol overdose.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[18] Assessment of the evidence</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>I heard from 20 witnesses, details of whom are given as an appendix to this determination. I am satisfied that each and every witness did their best to give truthful evidence, even where, as in the cases of Dr Das, Melanie Gale, and Lesley Murray that had the potential to implicate them in the iatrogenic overdose. It was clear to me that with the tragic and momentous exception of the paracetamol overdose, Danielle received attentive, focused and appropriate care.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[19] Given the consensus about the cause of death, it is not necessary to comment in detail upon the evidence. I have given a narration of the evidence in the findings in fact, but I do wish to make some observations in connection with some of the witnesses.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[20] In the course of his evidence, Dr Overell was asked who was ultimately responsible for the prescription. His response was to the effect that "everyone was responsible"; however that has to be tempered with his evidence that he as a consultant he rarely prescribed drugs himself; it would tend to be left to junior staff. He himself was candid enough to accept that he had not known of the weight implication; he said that although he had not reviewed the Kardex he would have regarded the intravenous paracetamol prescription as "credible."</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[21] Dr Dillon was asked, in common with a number of the witnesses, whether any particular measure might have prevented the accident. He volunteered that the Kardex might have a separate part for intravenous drugs administered, so that this was noted. Apart from observing that in this particular case, not one of the relevant professionals regarded the intravenous route as likely to have caused any different approach, it was quite properly put to him that the variation of the method of recording any information on medical records was the provenance of a committee. Three doctors had given evidence of three different regimes in three different health boards. I do not think that is for a sheriff in the context of this sort of enquiry to innovate upon or trespass upon the recording of such information. However, I make some observations at the conclusion of this determination in deference to the points made.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[22] I have dealt in the context of the findings in fact at paragraphs [xix] and [xx] with Dr Das's explanation for the prescription of the intravenous paracetamol. She was plainly still affected by her role in this matter. She gave her evidence carefully and honestly and did not attempt to minimise her role, but did explain clearly the thought process that lead to the prescription.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[23] Melanie Gale was the only nurse to give evidence whose involvement could be detected from analysis of the signatures on the Kardex. Her recollection was not perfect; the description she gave of Danielle as giggly and smiley could not be reconciled with the other evidence about her presentation. She said that she would normally, in an unfamiliar drug, check the BNF and then the monograph. She had administered intravenous paracetamol before; it was unusual but not unprecedented. She looked at the vial; She knew Danielle was over 33 Kg, but did not know how she knew it.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[24] She was asked about the dosage; her response was that the vial did not give any details about the dosage. She was referred to the </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>NMC</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> standards for medicines management; she said that she had followed these. She said that if she had had concerns, irrespective of the prescribing history, she would have raised them or acted differently. Her position was that there was nothing in the surrounding circumstances to cause her alarm. She assumed that the intravenous and oral dose were the same. This assumption was wrong.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[25] Lesley Murray also assumed that the doses were the same when she reviewed the Kardex on the 18<sup>th</sup> June; she was subject to the same prevailing assumption. She did not check. It did not occur to her to check.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[26] Submissions of parties in relation to the evidence</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>I heard from the Crown first, then Mr Hunter, then Miss Donald and then Mr Stephenson. The latter two provided written submissions which are not rehearsed in this Note but extracts of which are contained in the appendices to this determination.. </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[27] Miss Adair referred me to section 6(1) of the 1976 Act where guidance is given as to the purpose and function of the determination. She invited me to find that Danielle died at </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>10.25 am</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> on </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>24 June 2008</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> at the Royal&nbsp;Infirmary of Edinburgh.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[28] She invited me to find that the cause of death was liver failure due to paracetamol toxicity. She recognised that the focus of the Inquiry had narrowed considerably and the cause of death was less contentious. Professor Pounder's report should be disregarded. She said there was ample evidence accepted by all that from the period 17 June until 22&nbsp;June Danielle was given 20 doses of intravenous paracetamol at one gram when each dose should have been 525 milligrammes.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[29] Dr Dillon's evidence was to the effect that the level administered would have had a toxic effect and the prolonged nature of the administration complicated matters. </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[30] She observed that no liver function test had been carried out at the Southern General Hospital on 21 June. </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[31] She said that there was conclusive evidence the cause of liver failure which in turn led to the multiple organ failure causing her heart to enter ventricular fibrillation and disastrously lowering her blood pressure causing death.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[32] She submitted that the post-mortem findings including the zone 2 and 3 necrosis in the liver were classic signs of paracetamol toxicity. In her submission were the pathological process or disease contributed to Danielle's death. </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[33] So far as the cause of the accident was concerned she said that there were three aspects, the initial prescription of the paracetamol at one gram four times per day; the administration of 20 such doses over five days informed by a false perception of familiarity and three the complicity amongst the clinicians who as a consequence of the widespread of availability in use of oral paracetamol and the similarity in dose in adults considered that no check required to be made in relation to Danielle's weight. No alarm bells rang. No one realised that an unfamiliar route gave rise to a different prescription. There were 21 clinicians not one properly considered the administration.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[34] She moved on to consider the precautions under section 6(1)(c). The first suggestion was that intravenous paracetamol should not routinely be available in non-surgical wards or wards where there is no familiarity. She considered the necessity of ordering the paracetamol might have caused further enquiry or questioning. She submitted that it was a failure or mistake to have the paracetamol routinely available when there was not a high level of familiarity with that preparation of paracetamol. She submitted that if it had to be ordered from a pharmacy there might be a deeper consideration that is clinicians may not have regarded it as standard or routine and matters would have been more thought through. </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[35] She then submitted that had there been universally issued guidance or warnings in relation to those under 50 kilograms that might have rang alarm bells.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[36] She referred to the formulary bulletin which did not contain information about the difference between the intravenous preparation and the oral preparation. No other guidance was issued before the incident to alert staff of the particular risks to particular groups. She accepted that it may not be practical to issue guidelines to all clinicians on all drugs but in circumstances where paracetamol was used regularly and frequently there should have been a widespread dissemination. Paracetamol intravenously stood on its own.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[37] I asked her who would be responsible for dissemination such information. She said at the level of directorate. I asked where the buck would stop. She said responsibility went to the Board level who were responsible for disseminating information. She then made a submission that the Board needed to identify particular issues, particularly drugs so that important information about particular risks were brought to the attention of clinicians. That seemed to be a general observation rather than a precaution that could be imposed.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[38] She submitted that an obvious precaution was the level of prescribing. Dr Das told the court in hindsight that she should have checked the BNF, however, at the time and in the context in which she was prescribed intravenous paracetamol no alarm bells rang for her. It was submitted that the drugs was unfamiliar to her as she had not previously prescribed it and clarification and guidance ought to have been sought.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[39] There was evidence that the patient information leaflet had appropriate and relevant information but this was not necessarily to hand when the nurse picked it up the preparation for administration. She submitted that a reasonable precaution would be to include on the vial label a warning such as "CAUTION IF PATIENT IS LESS </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>THAN</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> 50 KILGRAMES".</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[40] She noted that Danielle's weight was not recorded on the Kardex. She submitted that was a precaution that should have been taken. She accepted that in some Health Boards there was no space for weight to be put and Dr Das, even if she had known Danielle's weight, would not necessarily have reduced the dose. She submitted nonetheless that it was a reasonable precaution, to have included Danielle's weight.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[41] She then submitted that every patient when being reviewed by either a doctor or a pharmacist should be seen. Danielle was not seen by Dr Das nor Lesley Murray. Neither were told of any issue but everybody who spoke to having a physical memory spoke to Danielle being small </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[42] She submitted there was evidence from Lesley Murray that pharmacists in reviewing the Kardex will take weight into account. She submitted that if Lesley Murray had seen Danielle and realised that she was not a standard size adult it might have occurred to her to have a closer look at the doses. </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[43] She submitted that although there were resource issues it was a reasonable precaution </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[44] She also made a submission that there should be an identifiable clinician who retains responsibility for a patient even if that patient is transferred from ward to ward<b>.</b> It was plain that Danielle's Kardex was reviewed but was generally overlooked on the basis that no clinician saw anything sinister about the paracetamol prescription. She thought there might be some substance in Dr Dillon's suggestion that there was a separate intravenous section on the Kardex (although Dr Dillon had to concede that in his own Health Board that did not happen). There was a concern about the chain of responsibility. Dr Overell indicated that everyone was responsible but that there was no clear structure responsibility </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[45] She indicated that the transfer from ward to ward was part of the issue. It was not considered to be of great importance. It might be a precaution for a doctor renewing a prescription chart to initial each prescription that would have the dual benefit of showing that they had considered each prescription and it would provide an audit trail (however, there is no room on the form for that to be done; the space is already insufficient for identification of the initials of the administering nurses).</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[46] Finally, she submitted that it would have been a reasonable precaution for Danielle to have had biochemistry tests every day in order to facilitate early detection of any abnormal results. It may have been spotted prior to 21 June allowing the antidote to have been prescribed at an earlier date. She submitted that was reasonable </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[47] Miss Adair then addressed section 6(1)(d) the defects. She thought there was a defect in Greater Glasgow Health Board approving a new formulation of a drug with which most staff were highly familiar when there was a risk associated with it. There was a failure to train staff and issue guidance and warnings. The formulary bulletin had no information about the implication of weight to dosage.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[48] She thought there was a defect in the system whereby pharmacists had not reviewed her Kardex in conjunction with seeing her. She was only seen by Ms Afzal. She thought that was a dangerous practice. She thought that a patient should be seen on a daily basis by a ward pharmacist. That had been a defect. She restated her submission that every patient being reviewed should be seen. She submitted that it was not imposing a much greater burden to have the notes and to look at them in the presence of the patient, it would address human error. She considered it was reasonable. </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[49] She said so far as the other facts were concerned there was not a robust system of review of the prescription chart either on the ward or at transfer.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[50] Mr Hunter agreed with the Crown submissions in relation to formal findings that considered that there was room for the court to add that paracetamol toxicity was due to iatrogenic paracetamol overdose. He described the doctors at the Southern General as being responsible for deplorable failings. Danielle need not have died. He thought it was insufficient to call it regrettable. She entered a hospital ward with an undetermined condition possibly atypical pneumonia which she appeared to be recovering. This was successfully treated by a combination of anti-viral and antibiotic medication. At post-mortem there were no signs of any other significant organ damage causing death.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[51] He submitted that Dr Das had simply got it wrong. She did not deny that. She expected a review of dosage. That was where things had gone wrong. She was unaware of the weight consequent as was everyone else. He could not necessarily agree that in all cases a patient required to be seen. The issue was her weight. The records about her weight were incomplete. </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[52] He accepted that from the evidence of Julie McQueen it was clear that a number of changes were recommended. Danielle was seen by 11 nurses and 12 different doctors. She received 20 doses. The doctors were at all level and not one of them noted the overdose. He described it as a lamentable failure of all professional. All were responsible. There was a deplorable laxity.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[53] He appreciated that the Health Board could not over label the vial but suggested a recommendation to the MHRA about labelling; if this was made sufficiently clear by a label whoever was administering the dose would have identified the risk in relation to low weight. He accepted that a number of things had gone wrong but many had been addressed by the Critical Incident Review.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[54] He then made submissions that the antidote had been issued too late. His point was that earlier detection, for example, by the liver function tests would have meant earlier application of the antidote which was familiar.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[55] He thought that the inter-ward transfers and the inter-hospital transfers were areas of concern because of the lack of record. It seemed to have been addressed to an extent but the failure to identify signatures and names was unhelpful. Records were only useful if complete.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[56] He acknowledged there were obvious difficulties with information and education. Dr&nbsp;Dillon had asked a number of people; nobody had known about the intravenous paracetamol administration. In his submission the medical staff should have known anyway, but if they did not know, the vial should have informed them of the appropriate dose. He said complacency was at the root of this. The clinical handbook which junior doctors had did not give any warning. The BNF did do.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[57] He was concerned about the information contained in the Kardex. Her death should have been avoided. The family just wished that this would not happen again. Intravenous paracetamol itself was not the issue. It was the system around it which needed to be considered.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[58] Miss Donald's submissions were made in writing. She had nothing to add to these. Mr&nbsp;Stephenson's submissions were made in writing. He did take the opportunity to respond to the submission by the Crown.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[59] In the first place the Crown had suggested that intravenous paracetamol should be available in surgical wards only. He submitted that the proposal was too wide and too general and too unspecific. There was insufficient evidence. If drugs were not immediately accessible then there may be different risks and issues. </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[60] So far as the dissemination of information was concerned, again, he regarded the submission as being vague. It seemed to rest the responsibility on the Health Board. There was no evidence to support it. It was speculative but the Health Board had a strategic role and would not have responsibility for disseminating information.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[61] The next issue he addressed was the weight on the Kardex. He admitted that it was clear from the evidence that other Health Boards did not have a space for weight. It was not clear what the nursing notes said about weight but the issue was not her weight but that nobody appreciated the significance of it. </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[62] So far as the recommendation that someone reviewing the Kardex or the notes always sees the patient, it was not enough for the Crown to say that would just take a little bit longer as the resource was already there to carry out the review.<b> </b>There is no evidence whatsoever about whether it made any difference and what's more, such a recommendation could not be simply not beneficial but positively harmful by not addressing the gaps that would then appear in the care. He gave as an example Lesley Murray's evidence about having to provide a scoping report to justify her position as a full-time ward pharmacist at the </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>INS</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> in Ward 67. He submitted that it bordered on the irresponsible to submit that the court should impose a different system on the basis of the limited evidence heard.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[63] So far as the countersigning the Kardex was concerned, he said there was no space in that; similarly in relation to a separate intravenous section, individual hospitals could not just innovate on their own notes. It is a different balancing exercise as notes need to be accessible and intelligible and another layer in the Kardex forms to be signed will just increase the "paper haystack around the information needle". </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[64] So far as the concerns about the transfer between wards and hospitals were concerned the absence of the nursing notes made it difficult to know what information was transferred. It was clear that some papers go with her. </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[65] Finally, in relation to suggestion of a liver function test every day, this went too far. In any event there had been no evidence about why there had been no such test; no one was asked about it and it may have been as a result of the potential improvement<b>. </b>He submitted that it was an invasive procedure to take tests every day. It involved the taking of blood. If it is not for every patient, then the evidence would need to give a basis for determining the criteria for inclusion. Again, he considered that to make such a recommendation would over reach the function of the sheriff. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[66] Discussion</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>A Fatal accident enquiry always proceeds with the benefit of hindsight; it is much easier from that standpoint to identify what went wrong and what should have happened.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[67] However what was clear from this exercise was that there was a gap in the knowledge of all those who prescribed, administered, reviewed and considered the intravenous paracetamol prescription; none of these individuals knew that paracetamol was prescribed differently if administered intravenously and if the patient weighed less than 50kg. Each who was asked explained that they were familiar with paracetamol, that it was generally safe and that it did not occur to them to check the dose. Dr Dillon, as referred to by Mr Hunter, had conducted an informal poll amongst his staff and colleagues . </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[68] Not one person had appreciated that the intravenous dosage had different parameters.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[69] For obvious reasons, the spotlight has shone with particular focus on Dr Das; she was clearly, from her evidence, still very troubled by her involvement in this overdose. Her account was intelligible in relation to her particular actions. She was left a note to prescribe an intravenous analgesic; she was familiar with paracetamol; there had been a previous prescription of intravenous paracetamol, albeit with an oral alternative; she was in an adult hospital; there was no information in the documentation which she had to draw attention to the fact that Danielle was anything other than a normal 19 year old girl; Danielle was already receiving drugs intravenously so had an intravenous line. Intravenous administration of an analgesic was short term, with the oral route being reinstated as soon as practicable. Dr Das understood that the prescription would be reviewed, as indeed it was, for example by Lesley Murray. She has been subject to criticism for her failure to consult the BNF; however her own clinical handbook did not alert her to any paracetamol concerns. Similarly, even if she had seen the label, it did not in terms highlight the prescription for someone of Danielle's weight. Dr Das did not strike me as irresponsible or complacent. On the contrary she appeared to be a diligent and conscientious if inexperienced professional, and whilst she was clearly busy on the evening of the initial prescription, that did not affect her thought process.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[70] Melanie Gale, whose signature was the only one apparently decipherable enough to identify, acted as a representate of all the nursing staff. She had not appreciated that there was anything unusual in the administration of the intravenous dosage so did not check the BNF. Although there were defects in her recollection she did not come across as complacent, or irresponsible and I accepted her evidence that, had she had concerns, she would have checked the position.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[71] Similarly, Lesley Murray is the one pharmacist who can be identified as reviewing the Kardex in the context of the ongoing intravenous paracetamol. She did not check the dose; it did not occur to her to check. Again she did not come across as irresponsible or complacent. I am satisfied that had she had concerns she would have addressed such concerns.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[72] There was no systemic failure identifiable from the evidence led. The failure was a prevailing and pervasive failure to appreciate the particular peculiarities of the intravenous dosage of paracetamol, a lack of knowledge and experience shared by 23 different professionals who dealt with Danielle and indeed by a number of the witnesses who gave evidence, as spoken to by Dr Dillon. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[73] The three precautions which I have identified are easy to determine with the benefit of hindsight; the accumulation of evidence demonstrated that no professional expressed any concern about the use, or dosage of the intravenous paracetamol. It is unfortunate to single out individual practitioners for attention when they acted intelligibly, if wrongly, given the state of knowledge which prevailed. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[74] There was a prevailing attitude that paracetamol was so familiar that no further enquiry was required., Danielle's presentation was unusual in terms of her weight in an adult hospital. These factors combined tragically so that she received an overdose on a sustained and regular basis, which led to her death.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'></span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[75] There was no identifiable shortage of information about the intravenous administration if the medical personnel had felt the need to check; the tragedy is that no-one did. The BNF and the monogram both gave specific information. The clinical handbook and the label did not; neither purport to be comprehensive.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[76] In relation to the steps to be taken I am satisfied that there are no additional recommendations which it is appropriate to make on the basis of the evidence led. </span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[77] This is for two reasons; firstly I have regard to the steps taken (contained in appendix 5 and spoken to in some detail, by the witness Julie McQueen) and the evidence that intravenous paracetamol had been withdrawn from general use; secondly I have regard to the need to guard against over-reaching my powers. This has not been a general enquiry about, for example, the practices and protocols of prescription in hospital, or the uniformity or otherwise of medical notes. These are matters which are already subject to intelligible and informed structures..</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[78] In relation to the submissions not already dealt with about recommendations, or defects I have some observations. Miss Adair submitted that a reasonable precaution would be to include on the vial label a warning such as CAUTION IF PATIENT IS LESS </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>THAN</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> 50 KILGRAMES. However it was clear that the labelling of medicines is such that an ad hoc local solution is neither practicable nor desirable.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[79] The crown proposed that the prescriber of any drug always saw the person for whom the prescription was written. However<b> </b>the physical presentation of a patient is sometimes of no assistance at all to those prescribing. They may obtain much more information from blood tests, clinical notes, scans, or x-rays. Even those who had seen Danielle did not necessarily link her small stature to a need to scrutinise the dose of paracetamol. There was no evidence about the additional time that would be required for such an exercise to be undertaken.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'></span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[80] In relation to the Crown's suggestion that metabolic checks should be done every day, this seems to me to be trespassing entirely on the clinical judgement of the professionals involved. This is particularly so when there was, as was noted by Mr Stephenson, no explanation or exploration of why no such tests were carried out there may have been very good clinical reasons including an apparent improvement for such a position.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[81] Miss Adair had also addressed section 6(1)(d) in relation to whether there are any defects. She thought there was a defect in Greater Glasgow Health Board approving a new formulation of a drug with which most staff were highly familiar when there was a risk associated with it. I do not regard the evidence as disclosing any defect. There was information in the BNF and on the information sheet provided by the Health Board (at pages 305-306 0f the productions). There was no lack of accessible information. There was a failure by staff to appreciate the need to consult such information for the reasons given above.</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>[82] Miss Adair, Mr Hunter and Mr Stephenson all made comments about the transfer between hospitals, when Danielle was transferred from SGH to the RIE; the evidence was insufficient for any conclusions to be drawn but it remained noteworthy that there was uncertainty amongst the professionals about what records would be sent </span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[83] Finally, it is appropriate to record those matter which were left unresolved but which might merit some attention.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[84] No-one reported this death despite there being a clear obligation to do so and despite the clear impression even from the outset that Danielle died as a result of an iatrogenic overdose. The matter was not really explored in evidence, but suggests either an absence of protocol about reporting such a death, or an absence of familiarity with any such protocol.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[85] The Kardex system was a matter of some comment in both evidence and submission, but given the provenance of the blank medical record notes, which are prepared after consideration and consultation and which are not, perhaps surprisingly, uniform within the NHS in </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>Scotland</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>, it is inappropriate to make any recommendations. However, I make the following observations </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[86] It is trite that Medical records should be accessible and intelligible; I share the concern put in a neat phrase by Mr Stephenson that parties should warn against surrounding the information needle with a paper haystack, and these observations must be put in that context.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[87] Dr Wallace had given evidence that the weight should have been included on the Kardex. There was space for it in the Kardex relating to Danielle. However, her experience in her role with a different health board was that the kardex did not have a space for weight. Whilst in this case I cannot hold on the evidence that the recorded weight would have alerted any clinician to the appropriate dosage, such information may have a material role in assessing dosage or route of administration. It seems to me that weight can be an important factor and should have space to be noted, and be noted.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[88] Similarly there is no means of recording on the Kardex the existence of unusual metabolism or condition; there was some evidence that Danielle's condition could give rise to difficulties for venous access, or rectal dosage. Consideration may be given to space being afforded for such information.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'></span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[89] There was no means available to anyone reading the Kardex of knowing whether or not the Kardex had been reviewed by ward pharmacist or any other person. Assumptions were made about reviews which could not be vouched by any record of such review. Consideration might be given to affording space on the Kardex for such a review to be recorded.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>[90] Most signatures on the Kardex were indecipherable. I noted that the medical records from the ERI included a column for writing the name of the noter and their designation in block capitals. This did not seem to have been uniformly observed. Notwithstanding that failing, consideration might be given to such a space being uniform in all medical records, for ease of identification of the professional staff involved.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Sheriff Andrew M Cubie</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Appendix to the FAI determination re Danielle Welsh </span></b></p><p class=MsoNormal><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p class=MsoNormal><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Appendix number 1</span></b></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>List of witnesses to the enquiry and their status at the time of the enquiry.</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>For the Crown</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><ol style='margin-top:0pt' start=1 type=1><li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Margaret McInally or Welsh, Danielle's mother</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>John Welsh, Danielle's father</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Dr Rowan Wallace, Consultant in Geriatric Care</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Dr Shamita Das, Physician</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Dr Susan Fraser, Consultant in Medicine and Rheumatology</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Fiona Walker,Lead Directorate Pharmacist</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Lesley Murray, Advanced Pharmicist</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Elaine Morrison, Consultant in Medicine and Rheumatology</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Dr Digby, Consultant Anaesthesia and Intensive Care</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Dr James Overell, Consultant Neurologist</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Linda Robertson, Lead Nurse Medical Specialities</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Melanie Gale, Charge Nurse</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Dr Carol Blair, Consultant Hepatologist</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Dr David Semple, Consultant in Anaesthesia and Intensive Care</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Dr John Currie, Consultant in Anaesthesia and Pain Management</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Julie McQueen, Clinical Risk Manager</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Dr Julie McAdam, Forensic Pathologist</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Professor Alastair Burt, Chair of Pathology, </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>University</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> of </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>Newcastle</span></li> <li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Dr John Dillon, Consultant Hepatologist.</span></li></ol><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>For the Health Board</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><ol style='margin-top:0pt' start=1 type=1><li class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Saima Afzal, Pharmacist</span></li></ol><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><span lang=EN-GB style='font-size:12.0pt;line-height:150%;font-family:"Palatino Linotype"'><br clear=all style='page-break-before:always'></span><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Appendix to the FAI determination re Danielle Welsh </span></b></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Appendix number 2</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Glossary of selected medical and technical terms</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>BNF </span></b></p><p class=MsoBodyText style='line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype";color:#333333'>The BNF is a joint publication of the British Medical Association and the Royal Pharmaceutical Society and provided for national circulation. </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>The BNF is intended mainly for doctors, pharmacists and nurses in the National Health Service. It is designed as a rapid-reference digest and provides up-to-date guidance on the selection, prescribing, dispensing and administration of medicines. The BNF details all the medicines that are generally prescribed in the </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>UK</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>, with special reference to their indications, cautions, contra-indications, side-effects, dosage and relative costs. </span></p><p class=MsoBodyText style='line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Clinical Handbook</span></b></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>The Clinical handbook referred to in these proceedings is provided by the NHS Greater Glasgow and and C Acute services division and is a readily portable and accessible resource on evidence based routine clinical practice; it is available in the GGHB intranet. Every doctor will have a copy or very quick access to a copy either in book form or on the intranet.....</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Kardex</span></b></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>This was formally the name for a filing system for nursing records and orders that was held centrally on the ward and contained all the nursing details and observations of patients that had been acquired during their stay in hospital. Although this system is no longer used for nursing records, since care plans are now held at the patient's bedside rather than centrally, the term 'Kardex' continues to be used generically, for certain patient record systems whether held centrally or otherwise; in the context of these proceedings the Kardex refers to the record of drugs administered to Danielle.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>NMC</span></b><b><span lang=EN-GB style='font-family:"Palatino Linotype"'> Standards for medicines management book</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>The </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>NMC</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> is the Nursing and Midwifery Council, which regulates the two professions of nursing and midwifery; inter alia it maintains a register of all nurses and midwives eligible to practice in the </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>UK</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> . It provides advice and guidance to registrants. The book seeks to "set standards for safe practice in the management and administration of medicines" by registrants , and provide "the minimum standard by which practice should be conducted and...provide the benchmark by which practice is measured."</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Paracetamol</span></b></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p style='line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>Paracetamol is an analgesic, thereby relieving pain, and an antipyretic , whereby it lowers fever. The trade name of the intravenous paracetamol product used in the case is perfalgan. Perfalgan is indicated for the short-term treatment of moderate pain, especially following surgery and for the short-term treatment of fever, when administration by intravenous route is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible.</span></p><p style='line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>Effect of overdose; There is a risk of liver injury (including fulminant hepatitis, hepatic failure, cholestatic hepatitis, cytolytic hepatitis), particularly in elderly subjects, in young children, in patients with liver disease, in cases of chronic alcoholism, in patients with chronic malnutrition and in patients receiving enzyme inducers. Overdosing may be fatal in these cases. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><span lang=EN-GB style='font-size:12.0pt;font-family:"Palatino Linotype"'><br clear=all style='page-break-before:always'></span><p class=MsoNormal><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Appendix to the FAI determination re Danielle Welsh </span></b></p><p class=MsoNormal><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p class=MsoNormal><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Appendix number 3</span></b></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>Excerpt from written submissions by the GGHB</span></p><p class=MsoNormal style='line-height:200%;text-autospace:none'><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><p class=DefaultText style='text-align:justify;line-height:200%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Facts</span></b></p><p class=ListParagraphCxSpFirst style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Danielle Welsh (Danielle) was born on </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>5 June 1989</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>. She died in the Intensive Care Unit of the Scottish Liver Transplant Unit at the Royal Infirmary of Edinburgh (RIE) at 10.25 on </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
 font-family:"Palatino Linotype"'>Tuesday 24 June 2008</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'> aged 19. <b>[Section 6(1)(a)]</b> She was transferred to the RIE from the Southern General Hospital, Glasgow in the early hours of </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>Monday 23 June 2008</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'> suffering from fulminant liver failure. Danielle had been an inpatient at the Southern General Hospital following her presentation at the Accident &amp; Emergency Department of the Hospital late on </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:
 "Palatino Linotype"'>Sunday 15 June 2008</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>.</span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>For the purposes of the Inquiry I accept the evidence of Professor Burt and Dr Dillon as to cause of death. Accordingly the cause of Danielle's death was paracetamol toxicity caused by a cumulative overdose of intravenous paracetamol prescribed and repeatedly administered in Wards 21, 67 and 25 of the Southern General Hospital between the evening of Tuesday 17 and </span><span lang=EN-GB style='font-size:12.0pt;line-height:
 200%;font-family:"Palatino Linotype"'>Sunday 22 June 2008</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>. This resulted in Danielle developing acute liver failure by </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>22 June 2008</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>, and suffering a terminal event in the form of a series of heart attacks at the RIE on the morning of </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>24 June 2008</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>. I also accept the unchallenged evidence of Dr Dillon (in chief and as modified in cross-examination on being advised of the liver function results from 20 June) that had IV Paracetamol been stopped and, if necessary, Danielle treated for paracetamol overdose, at any time up to 20 June 2008 it is likely she would have survived. In the event it was not appreciated that she had received an overdose until 22 June, by which time despite appropriate treatment in the Southern General Hospital and the RIE, events proved it was too late to avoid her death. It appears to follow from Dr Dillon's evidence that on the balance of probabilities no act or omission occurring on 21 and </span><span lang=EN-GB style='font-size:12.0pt;line-height:
 200%;font-family:"Palatino Linotype"'>22 June 2008</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'> caused or materially contributed to Danielle's death. <b>[Section 6(1)(a) and (b)]</b> </span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Danielle's parents are John Welsh and Margaret McInally or Welsh. Danielle had two siblings, an older sister Catherine and a younger brother, Martin. Mr and Mrs Welsh have attended throughout the Inquiry, showing considerable dignity and restraint. It is clear that Danielle's death has had a considerable impact on them. I would take the opportunity to convey to them my sympathy for their loss and that of Greater Glasgow Health Board. I hope that the Inquiry will ultimately provided some closure for them.</span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Danielle had congenital condition giving rise to longstanding learning disability, hearing impairment, short-sightedness, spondylo-epiphyseal dysplasia (a disorder resulting in abnormal bone formation and short stature), and delayed puberty. Her sister Catherine suffers from the same genetic syndrome. At the time of her death Danielle was 3 feet 11 inches tall. Although at autopsy she was noted to weigh 41.9kgs this was in part due to fluid-loading caused by necessary and appropriate medical treatment during the last 36 hours or so of her life. Her normal weight was 35kgs [kilograms to pounds conversion factor 2.2046; 35kgs x 2.2046 = 77.161 lbs = 5.5115 stones]. It would have been obvious to anyone who saw Danielle that she was of short stature and (although not underweight for her height) might well weigh less than 50kgs [kilograms to pounds conversion factor 2.2046; 50kgs x 2.2046 = 110.23 lbs = 7.87 stones]. It was a feature of Danielle's condition that she suffered considerable pain in her hips, for which she was prescribed analgesic drugs. Despite her medical problems Danielle had a friendly out-going personality. She was socially engaged and enjoyed a good quality of life. She had a happy and loving home life with her parents and siblings.</span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Until 2008 Danielle and Catherine were under periodic medical review at the </span><span lang=EN-GB style='font-size:12.0pt;
  line-height:200%;font-family:"Palatino Linotype"'>Royal</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'> </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:
  "Palatino Linotype"'>Hospital</span><span lang=EN-GB style='font-size:12.0pt;
line-height:200%;font-family:"Palatino Linotype"'> for Sick Children, Glasgow (Yorkhill); latterly by Dr Donaldson, Consultant Paedetrician, by Dr John Currie, a Consultant Anaesthetist with a special interest in pain relief and by Mr. Sherlock, a Consultant Orthopaedic Surgeon. They were also under the care of their GP. By June 2008 Danielle's hospital care was in the course of transfer from Yorkhill to the Southern General Hospital. She had already seen Mr Sherlock there. She was waiting to be seen at the Pain Clinic of the Southern General Hospital. Danielle had already exceeded the age at which care would usually be transferred to an adult hospital. Although Mrs Welsh expressed some regret that the transfer had taken place there was no evidence that it was other than medically appropriate. Danielle was an adult. </span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>By June 2008 Danielle's regular analgesic regime comprised Tramadol (an opoid painkiller) and paracetamol. She was also prescribed Cyclizine (an anti-emetic) for reasons not apparent from the evidence. She was prescribed hormone tablets with a view to accelerating puberty.</span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>7.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>As the focus of the Inquiry has come to be on paracetamol it should be noted at this point that the drug is a widely available non-opioid analgesic which can be obtained without prescription in the </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>United Kingdom</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>. It is also known as Acetaminophen. It is usually supplied in the form of tablets (oral paracetamol). It can also be administered per rectum or intravenously. The standard adult therapeutic dose for oral paracetamol is 1 g four times daily. This is also the standard therapeutic dose in children from the age of 12. [Crown Production No.9 page 298, British National Formulary, dated March 2008]. Doctors, pharmacists and nurses are likely to be very familiar with the use of oral paracetamol, and to be aware of the standard dose. Paracetamol in excess can be toxic to the liver and may result in acute liver failure leading to death. Voluntary drug overdoses often involve ingestion of paracetamol. The clinical manifestation of paracetamol toxicity is delayed and may only manifest up to 96 hours after ingestion. Again doctors, pharmacists and nurses are likely to know this. This has to be seen in context. In day to day hospital practice drugs that could be toxic in overdose are used; many will be as, or more, intrinsically dangerous than paracetamol.</span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>8.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Whereas paracetamol given orally has been in widely used since the 1950's IV paracetamol has been marketed only in recent years. The sole manufacturer is Bristol-Myers Squibb Pharmaceuticals Limited (Bristol-Myers) who market their product under the name Perfalgan. The IV paracetamol given to Danielle was Perfalgan. Bristol-Myers were not present at the Inquiry. I understand the Inquiry was not intimated to them by the Crown. Solicitors acting for the Health Board brought the Inquiry to the attention of Bristol-Myers a week or so before the resumed diet. </span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>9.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>The manufacture, sale and provision of medicinal products has been regulated in the </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>United Kingdom</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'> by a licensing system since the Medicines Act 1968. The Act has been heavily amended. A large number of Regulations have been made under the Act. Much of the national regulatory framework is based on EC Directives. Part V of the 1968 Act enables Regulations to be made governing packaging, labelling, leaflets, etc. For the Act (not fully updated) see </span><span lang=EN-GB><a href="http://www.statutelaw.gov.uk/legResults.aspx?LegType=All+Legislation&amp;title=medicines+act&amp;Year=1968&amp;searchEnacted=0&amp;extentMatchOnly=0&amp;confersPower=0&amp;blanketAmendment=0&amp;sortAlpha=0&amp;TYPE=QS&amp;PageNumber=1&amp;NavFrom=0&amp;activeTextDocId=1662209"><span style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>http://www.statutelaw.gov.uk/legResults.aspx?LegType=All+Legislation&amp;title=medicines+act&amp;Year=1968&amp;searchEnacted=0&amp;extentMatchOnly=0&amp;confersPower=0&amp;blanketAmendment=0&amp;sortAlpha=0&amp;TYPE=QS&amp;PageNumber=1&amp;NavFrom=0&amp;activeTextDocId=1662209</span></a></span></p><p class=ListParagraphCxSpMiddle style='line-height:200%;text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>The Medicines and Healthcare products Regulatory Agency (MHRA) was set up in April 2003 being a merger of the Medicines Control Agency and the Medical Devices Agency. The MHRA is the government agency which is responsible for ensuring that medicines are acceptably safe. ("This body monitors approval mechanisms, controls licensing arrangements, and issues rapid warnings when evidence comes to light of a public danger concerning the use of a product or device.", Mason &amp; McCall-Smith, <i>Law and Medical Ethics</i>, 7<sup>th</sup> edition 9.105). The MHRA is an executive agency of the Department of Health. No evidence was heard at the Inquiry as to the terms of the licence granted in respect of Perfalgan: there must be a licence even if primarily granted in another EC country. The extent to which any leaflet or packaging supplied with Perfalgen is prescribed under the applicable licence was not dealt with in the evidence. </span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>10.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Use of medicines in the Scottish NHS depends upon acceptance for use by the Scottish Medicines Consortium. On </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>13 December 2004</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'> the Scottish Medicines Consortium issued Summary of Advice No.137/04 accepting 1g/100ml Perfalgan for use within NHS Scotland [Health Board, Fourth Inventory Production 5]. On </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>6 April 2005</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'> the Scottish Medicines Consortium issued Product Update No.172/05 accepting 500mg/50ml Perfalgan for use within NHS Scotland [Health Board, Fourth Inventory Production 6]. Neither gives any indication as to dosage although witness Pharmacist Fiona Walker spoke to a revision in the system of approval whereby dosage is now set out in the Summary of Advice. </span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>11.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>In order for Perfalgan to become available in the Southern General Hospital there required to be approval by the Health Board's Area Drug and Therapuetics Committee [?]. Perfalgan was approved in April 2005. There was nothing in the evidence to suggest that at the time of first introduction to the Southern General Hospital anyone had any reason to suspect that problems were likely to arise in the course of prescribers identifying dosage, or in connection with the subsequent checking of the dosage. It is not obvious that this would turn out to be the case, although events indicate it was. The contrary view might reasonably have prevailed in 2005: this was a new formulation of a familiar drug, and as with any other drug prescribers might reasonably have been expected to exercise proper professional care. Similarly other professionals (including pharmacists and nurses) might have been expected to exercise appropriate standards of care. There is no reason to conclude that Perfalgan ought reasonably in 2005 to have been singled out by the Health Board for special treatment. After Danielle's death the Health Board, having identified that a serious risk of prescriber error did exist in relation to Perfalgan took a series of steps which, in order to prove effective, eventually required a ban on the use of Perfalgan within their Medical Directorate, unless use could be specifically justified for an individual patient. (See further below.) This on any view was an extreme step. There is no evidence that it would have been reasonable for this, or any lesser measures to have been taken before Danielle's death.</span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>12.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>No attempt was made in the evidence to formally identify and precisely define the extent of a doctor's professional duty to (a) check the correct dosage when prescribing a drug, (b) to check the correct dosages of the drugs a patient under his/her care was receiving. For example no General Medical Council code of conduct applicable to prescribers was produced or referred to in evidence. It is inconceivable that a prescribing doctor is not under a professional duty to prescribe a drug only when they know that the dosage is safe and appropriate, checking the correct dosage if unsure. In the context of civil litigation and duties owed to a patient this appears to be accepted: e.g., <i>Horton v Evans</i> [2006] EWHC 2808, [2007] PNLR 17, and Jones <i>Medical Negligence</i> 4<sup>th</sup> ed., 4-108. A Health Board as a doctor's employer must be entitled to place some reliance upon the correct exercise of such professional duties. It is not suggested that such reliance can be absolute as it was apparent form the evidence that prescriber errors do occur. It appeared to be accepted by Dr Fraser and Dr Overell that there was an onus on successive doctors responsible for patient care to review a patient's continuing medication and that correct dosage was being received.</span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>13.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Part of the role of the ward Pharmacist at the Southern General Hospital in June 2008 was to check patient drug Kardex to see that dosages were correct and that there were no likely adverse interactions between prescribed drugs. Pharmacists could also be contacted for advice when on duty, if required. Again no applicable formal code of conduct (e.g., issued by the Royal College of Pharmacists) was produced or referred to defining how a Pharmacist should go about their duties. However the checking of drug Kardex for prescriber errors was within their specific job remit.</span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>14.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>The only professional code of conduct referred to in evidence was the Nursing and Midwifery Council, Standards for Medicines Management, Crown Production No.6. The sole nurse who gave evidence was Melanie Gale. She accepted the applicability of the Standards to her and to the nurses who administered Perfalgan to Danielle at the Southern General Hospital. In particular she accepted the applicability of Standard 8 which includes the following: "You must know the therapeutic uses of the medicine to be administered, its normal dosage .... You must consider the dosage, weight where applicable, method of administration, route and timing." It is difficult to accept that the professional responsibilities of doctors and Pharmacists would fall below this standard.</span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>15.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Therefore the system in place at the Southern General Hospital in June 2008 to protect patients, including Danielle, against iatrogenic drug overdose involved the exercise of professional care and responsibility by doctors when prescribing drugs and when reviewing patients, Pharmacists when they reviewed Kardex or responded to requests for advice, and nurses whenever a prescribed dose was administered. </span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>16.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>At first use of Perfalgen at the Southern General Hospital was confined to Surgical Wards, for post-surgical pain relief. There appears to have followed a gradual expansion in use beyond Surgical to Medical Wards. There does not appear to have been any particular reason driving this process. By June 2008 use on Medical Wards at the Southern General Hospital was established but at the fairly low level of about 2 -3 [?] patients a month. There was then some limited experience of Perfalgen among some but not all staff on the Medical Wards. </span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>17.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Crown Label No.1 is an example of a vial of Perfalgan. The label of the bottle states that it is suitable for use by those weighing over 33kg (which would have included Danielle) but includes no advice as to dosage. The Health Board cannot affix their own prescribing instructions without then treating each prescription as being of an unlicensed drug, which would be impracticable [Fiona Walker]. Crown Production No.15 is a "PATIENT INFORMATION LEAFLET" produced by Bristol-Myers. As the name suggests the leaflet addresses the patient rather than a doctor, pharmacist or nurse (e.g., "ask your doctor or pharmacist", "This medicine has been prescribed for you.", "please tell your doctor or pharmacist", etc.). The dosage instructions refer to two categories, viz., "Adolescents and adults weighing more than 50kg" and "Children weighing more than 33kg (about 11 years old) but less than 50kg". Danielle, being an adult weighing 35kg, would fall into neither category. Multiple bottles of Perfalgan are supplied by Bristol-Myers together in a box: the witnesses varied as to the number of bottles to be found in the box but were agreed that there was only one leaflet per box. There was no evidence that a prescribing doctor would ever necessarily see a bottle of Perfalgan, or the leaflet. A nurse administering the drug would see the bottle and might or might not see the leaflet. However clearly there is scope for a leaflet to be discarded, separated or lost before the last bottle of Perfalgan in a box is used. The leaflet would be of dubious value to anyone seeking to discover the correct dosage for an adult weighing between 33kg and 50kg. In such cases it may simply be a source of confusion: as appeared from the evidence of Nurse Melanie Gale.</span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>18.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Crown Production No.7 is an example of a Clinical Handbook dated August 2007 that was supplied to junior doctors commencing work at the Southern General Hospital in 2007-8. Although it advises on dosages for paracetamol "by the oral or rectal route" it makes no mention of paracetamol given intravenously: its successor Therapeutics a Handbook for Prescribers, issued after Danielle's death in August 2008 (Crown Production No.8 gives specific advice in line with that given in the March 2008 edition of the British National Formula (BNF). Crown Production No.9 is a BNF March 2008 edition, and was current at the time of Danielle's time in the Southern General Hospital. It includes the following advice for intravenous infusion of paracetamol: "ADULT and CHILD 10-50kg, 15mg/kg every 4-6 hours, max. 60mg/kg daily." For an adult weighing 35kg, like Danielle, this suggests dosage of 525mg every 4-6 hours subject to a maximum of 2,100 mg a day. </span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>19.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>It is obvious that no one could be expected to retain accurately in their memory the dosages of all the drugs they might require to prescribe, review or administer. There is an implicit risk in proceeding on the basis of memory unless one is certain of one's recollection (and are correct). Prima facie a system that requires and encourages checking of dosage at point of prescription may be better than a system that "requires" learning and retention of remembered dosage: the former is less likely to produce error. Copies of the BNF were available on each Ward of the Southern General Hospital. Pharmacists had their own individual copies. The publication could be accessed online via the hospital intranet. Doctors, pharmacists and nurses routinely consult the BNF for drug administration and dosage information. This is the case even at consultant level - e.g., Dr Overell uses the BNF several times a day. There was no evidence to suggest that anyone in a senior position at the Southern General Hospital would or could have expected prior to Danielle's death that prescribers would prescribe any particular drug without first checking the appropriate dosage, particularly if they had no previous experience of the formulation. It is not to the point that prior to the death the Health Board did not issue specific information and alerts to staff about the need to prescribe IV Paracetamol by reference to weight in light adults. It seems fair to conclude this level of specific information could not be provided for all drugs, would run the risk of swamping staff if it was, and would in any event have to be a sustained and repeated effort to deal with staff turnover, including regular periodic influxes of junior doctors. That the system relied on the individual performance by skilled staff of their professional duties does not amount in the circumstances to a defect in a system of working: individual failures to implement or comply properly with the system are identified below. <b>There were no defects in any system of working (cf., individual departures from system) which contributed to the death of Danielle Welsh.</b> <b>[Section 6(1)(d)]</b> </span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>20.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Danielle and her parents presented to the Emergency Department of the Southern General Hospital at 23.23 hours on </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>15th June 2008</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>. The reason for presentation was Danielle's altered behaviour. She was reported to be shouting and swearing, or not speaking at all, and did not seem to recognise her parents. This was entirely out of character for Danielle. On arrival at hospital Danielle was seen promptly in the A&amp;E Department by a triage nurse and then by Dr Bardhan, a locum Registrar. The findings made are recorded in Crown Production No.2 at page 13. Dr Bardhan referred Danielle to the Medical on-call Specialist Registrar, Dr Rowan Wallace who attended and examined Danielle. Danielle was initially thought to be unresponsive but soon after became responsive. There was no history of alcohol consumption or recreational drug use. Her regular medications were recorded as tramadol XL 200 mg twice daily, cyclizine 50 mg twice daily, paracetamol 1 g three times daily, and ethinylestradiol 10 micrograms at night: recorded by Dr Wallace in her clinical note timed at 01.00 on 16 June [Crown Production No.2 page 16]. Examination found a very anxious demeanour and confused speech, heart rate was high, and there was an up-going left plantar response. Temperature, blood pressure, and other physical examination findings were normal. Laboratory tests showed raised white blood count (13.7 x109/L) and slightly elevated CRP (8 mg/L), both being non-specific markers of inflammation or infection. Other investigations including blood glucose, liver biochemistry, and electrolytes were normal. Serum paracetamol concentration was 3 mg/L, and no salicylates (aspirin and its derivatives) were detected. The initial diagnosis was delirium due to meningitis or encephalitis, or possible urinary tract infection. It was Dr Wallace's normal practice in June 2008 to ask the patient, or a family member, about the medication the patient was receiving prior to admission and, if appropriate, to prescribe the same drugs in the same quantities. Danielle's pre-admission medications were prescribed on the SGH drug administration chart, as above: being Drugs T, V, W and X on the Kardex, at page 56 of the Crown Production No.2. (Drug T is paracetamol prescribed appropriately at 1g orally three times a day.) At this point Dr Wallace was concerned that Danielle might have encephalitis or meningitis, being infection of the brain substance or the meninges respectively. She made arrangements for Danielle to have a CT Scan, intending if this was negative to seek a sample of cerebrospinal fluid by means of lumbar puncture, for testing. It appears by this time a decision was made to admit Danielle to the Medical Receiving Ward, Ward 20, for investigation and assessment. Patients do not remain long in Ward 20. Either they are discharged or they are transferred to another Medical Ward for further investigation and treatment.</span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>21.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>The serum paracetamol concentration of 3 mg/L found was a relatively low level. It excludes paracetamol overdose within 24 hours prior to the taking of the blood sample tested. Together with the normal liver investigations on admission the reading excludes any significant pre-admission overdose (intentional or unintentional) of paracetamol. The findings suggest that Danielle was able to metabolise safely her regular daily dosage of paracetamol and that there was no toxic accumulation of the drug within her body by the time of admission. </span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>22.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>The CT Scan of Danielle's brain was normal. Dr Wallace saw Danielle again at 03.45 on 16 June. A lumbar puncture was attempted but abandoned due to technical difficulties. An </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>MRI</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'> brain scan was considered but this investigation requires the patient to be still and Danielle was thought to be too agitated. Dr Wallace initiated anti-viral and antibiotic drug treatment that would hopefully cover the presumptive alternative diagnoses. Treatment was commenced at 0415 on 16th June with intravenous ceftriaxone 2g, aciclovir 350 mg, and benzylpenicillin 1.8 g. In her clinical note [Crown Production No.2 page 17] Dr Wallace noted in respect of the three drugs "prescribed according to weight / paediatric doses." Beneath this she wrote "Weight 35kg". The three drugs are appear as "Once and Only" drugs on the Kardes at page 51 and as Regular Prescription Drugs A, B and C at page 52. Dr Wallace's signature appears next to each prescription. Dr Wallace did not enter Danielle's height or weight on the Kardex although there are boxes for both [Crown Production No.2 page 51]. Such evidence as there was suggested that patient weight was commonly omitted from the Kardex: weight will only rarely be relevant to adult drug prescription and in at least one other Health Board areas the <i>pro forma</i> Kardex does not include a box for weight. In Danielle's case it would not be immediately obvious to anyone looking at the Kardex that Danielle's weight was low. It might be possible to infer that some unusual factor had been used to arrive at the dosages of the drugs prescribed by Dr Wallace at paediatric dosages, but there was no evidence suggesting how obvious (or not) this might be. </span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>23.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Also on 16 June Danielle was prescribed "As Required" 1g paracetamol "IV/PO" by a different doctor. This is Drug PP at page 60 of the Kardex. The prescriber's signature is illegible but is <u>not</u> that of Dr Wallace. "IV/PO" indicates "intravenous/per oral". One dose was administered at 06.45 on 16 June with no indication given as to which route of administration was used. It appears probable that Drug PP was prescribed at an unknown time between 03.45 and 06.45. The prescription was stopped at some point later on 16 June. In the bottom box of the entry is written "ON REGULAR TID". "TID" is a medical abbreviation indicating three times a day. This seems likely to be a reference to Dr Wallace's prescription of oral paracetamol, Drug T at page 56. The latter is the only TID prescription of paracetamol appearing on the Kardex. The "ON REGULAR TID" entry is in the handwriting of Pharmacist Lorraine Perry. Ms. Perry did not give evidence but there was hearsay evidence that she had undertaken a pharmacy review of Danielle in Ward 20 on 16 June. The time of day at which this took place is not known. She may have stopped Drug PP, or taken steps that lead to it being stopped. Drug PP is the first indication of the possible use of IV Paracetamol in Danielle's records. Whoever prescribed the drug appears to have proceeded on the basis that the correct IV and oral dosages were the same, or at least that both were acceptable. If so they were mistaken: see above.</span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>24.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>On 16 June at 10.30 Danielle was seen in Ward 20 by Dr Semple, a Consultant Physician who made an entry in the clinical records beginning at page 17 below the entry by Dr Wallace which recorded Danielle's weight. At page 21 a reduction of the (already paediatric) dosage of benzylpenicillin is noted, which would imply a continuing recognition of Danielle's low weight. Later in the day Danielle was transferred to Ward 21 under the care of Dr Fraser Consultant Physician. Dr Fraser saw Danielle on 17 and 18 June making entries in the clinical records at pages 22-25. Danielle was seen by junior doctors. Ward 21 was normally part of the responsibility of Pharmacist Lorraine Perry (who had seen Danielle in Ward 20) but on 17 to 19 June was covered by Pharmacist Saima Afzal. Ms. Afzal saw Danielle on the morning of 17 June and checked her anti-biotic drug dosages. When doing so Ms. Afzal consulted both the paediatric and adult BNFs. She was aware that Danielle's weight was 35kg and confirmed the dosages as correct for this weight. She has no recollection seeing the "As Required" paracetamol prescription Drug PP - which had been stopped the previous day. At this point Danielle's only prescription of Paracetamol was below the standard oral dose, being 1g three times a day (Drug T). This was not an excessive dose.</span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>25.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>By the evening of Tuesday 17 June Danielle was vomiting. Oral input was problematic. She was complaining of pain. During the evening the on-call Foundation Year 1 Dr Das was asked to attend Ward 21 with a view to prescribing IV pain relief and an IV anti-emetic. Crown Production No.20 is a screen-shot relating to a request received from nursing staff by the Hospital At Night Referral system. It appears to record tasking of a response to Dr Das at 22.00. If so Dr Das and one other junior doctor were covering the night-time requirements the Wards, and Dr Das' initial recollection that her attendance was earlier when she was the only doctor providing cover is incorrect. There is no evidence that the system for providing night cover was defective or under-staffed. At some point Dr Das attended the Ward. She had not had any prior dealing with Danielle or involvement with her care. She believes she did not see Danielle or her medical or nursing records, but only the Kardex which was laid out for her at the nursing station with a post-it indicating the requirements. She did not know what weight Danielle was. She prescribed IV paracetamol, at a dosage of 1 g four times daily, being Drug D. This was an individual and daily dose in excess of the maximums indicated by the BNF (see above). Dr Das also prescribed IV Cyclozine , being Drug E. Dr Das had not prescribed IV paracetamol before. She did not check the dosage. She did not know the dosage was weight-dependent for a patient weighing less than 50kg. Had she wished to do so she could have consulted the BNF. If she had done so she would have appreciated that in order to prescribe the correct dosage she would have to know Danielle's weight - or at least that she was over 50kg. With this knowledge it is a fair assumption that Dr Das would have made enquiries as to Danielle's weight before prescribing IV Paracetamol. Dr Das could then have accessed Danielle's nursing notes, or obtained the medical records, which were probably in the nearby doctors' room, but did neither. Previously medical and pharmacy staff in possession of the notes had been aware of Danielle's weight and had taken it into account when prescribing or checking drugs (see above). It is reasonable to conclude that had she accessed Danielle's medical records Dr Das would have known that she weighed 35kg. She could alternatively have spoken to nursing staff. She could have gone to see Danielle. As Dr Das did not check the BNF (or any other source of dosage advice) she did not reach the point of enquiry as to Danielle's weight. Even if Danielle's weight had been stated on the Kardex there is no reason to conclude that Dr Das would have perceived this as being of any significance, or that she would have been prompted thereby to check the BNF. She was proceeding on the mistaken assumption that the IV dosage was the same as the standard adult oral dose. If she had not prescribed IV Paracetamol in the dosage she did it is unlikely that the iatrogenic overdose would have occurred and that Danielle would have died. <b>It would have been a reasonable precaution whereby Danielle Welsh's death might have been avoided had Dr Das checked the British National Formula before prescribing IV Paracetamol for Danielle on the evening of </b></span><b><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>17 June 2008</span></b><b><span lang=EN-GB style='font-size:12.0pt;line-height:
200%;font-family:"Palatino Linotype"'>. [Section 6(1)(c)]</span></b></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><b><span lang=EN-GB style='font-size:12.0pt;line-height:
200%;font-family:"Palatino Linotype"'>26.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></b><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Danielle's Kardex indicates that in compliance with Dr Das' prescription 2 doses of IV paracetamol were given on the evening of 17 June. Danielle continued to receive the same dose on 18 [x4], 19 [x3], 20 [x4], 21[x4] and 22 [x4] June in Wards 21, 67 and 25. There is nothing to suggest that any of the administering nurses queried the dosage. (It would be unfair to single out Nurse Melanie Gale for criticism as she appears to have given only one dose, after several had already been administered by other nurses.) Each dosage administered was in excess of the normal dosage of IV Paracetamol and took no account of Danielle's weight. On the basis of Dr Dillon's evidence it would appear that the overdoses given on 21 and 22 were not causally related to the death in the sense that if they not been given death would still have occurred. There is no evidence to suggest these doses contributed to the time of Danielle's death. <b>It would have been a reasonable precaution whereby Danielle Welsh's death might have been avoided had</b> <b>the nurses who administered IV Paracetamol to Danielle between 17 and 20 June complied with the requirements relative to drug administration incumbent upon them in terms of Midwifery Council, Standards for Medicines Management, Standard 8, in particular by</b> <b>ensuring they knew the normal dosage of the IV Paracetamol to be administered by them and by considering in this connection Danielle's weight. [Section 6(1)(d)]</b></span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>27.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Pharmacist Ms. Afzal performed a Ward Round in Ward 21 at some point on Wednesday 18 June. She cannot now recollect the time of day at which she did this. She did not see Danielle on this occasion. The time of the Ward Round would be dependent on Ms. Afzal's other duties on that particular day, and it may not have taken place until the afternoon. Danielle transferred from Ward 21 to Ward 67 of the </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>Institute</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'> of </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
  font-family:"Palatino Linotype"'>Neurological Sciences</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'> in the course of the day. When visiting a ward the Pharmacist might have to prioritise patients and may not see all of them. Because Danielle was receiving IV antibiotics she would have been a priority patient and would have been seen by Ms. Afzal had she still been on the Ward. As Danielle was not seen on 18 June by Ms. Afzal the probability is that the Ward Round took place after Danielle had left the Ward. Ms. Afzal therefore had no opportunity to review Danielle following upon Dr Das prescription of IV Paracetamol. Ms. Afzal conceded at the time she would not have been aware that IV Paracetamol required to be prescribed in accordance with weight in light adults. This of itself misses the point. She was not asked whether had she reviewed the Kardex on 18 June she would have checked the BNF (paediatric and adult), as she had done the day before in respect of other drugs. There is no reason to conclude that she would not have done so.</span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>28.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>From Wednesday 18 June Danielle was a patient in Ward 67. Danielle's Kardex was reviewed there by Pharmacist Lesley Murray. She may not have seen Danielle in person. One of the purposes of the review was to look for prescription errors. This was an opportunity to review Dr Das' prescription and to correct it. Ms. Murray did not do so. In some respects her position is similar to that of Dr Das. She did not know that the IV and oral dosages of IV Paracetamol were different. She assumed that they were the same. The reason for the assumption is not obvious. She did not check. The need for intravenous rather than oral painkillers appears to have continued with Danielle still on a drip and being prescribed a second, additional, anti-emetic for nausea in the course of the evening. <b>It would have been a reasonable precaution whereby Danielle Welsh's death might have been avoided had Pharmacist Lesley Murray checked the British National Formula in respect of IV Paracetamol when reviewing Danielle's drug Kardex in Ward 67. [Section 6(1)(c)]</b></span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>29.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Danielle remained a patient in Ward 67 between the afternoon of 18 June and evening of 20 June, and was then transferred back to a different Medical Ward, Ward 25 from the evening of 20 June. The issues in the Inquiry are now narrowed so that the detail of her condition in each Ward and the investigations do not need to be addressed in detail. However the transfer to Ward 67 was necessary if serious brain pathology was to be excluded by </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:
 "Palatino Linotype"'>MRI</span><span lang=EN-GB style='font-size:12.0pt;
line-height:200%;font-family:"Palatino Linotype"'> Scan, only the </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>Institute</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'> of </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
  font-family:"Palatino Linotype"'>Neurological Sciences</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'> having the facility to perform the procedure under sedation. It also enabled a lumbar puncture to be performed. Having excluded a neurological explanation for Danielle's presentation it was reasonable and appropriate that she be returned to a Medical Ward. While it might be less than ideal that she was transferred to a different Medical Ward this appears to have been dictated by the availability of beds. Danielle seems still to have been quite unwell on 20 June, and was thought to have clinically worsening pneumonia, with a change of antibiotics to counter this commencing only in the evening of that day. There is nothing in the evidence to make one think that Danielle's treatment with IV paracetamol would not have continued as it did had she been transferred back to Ward 21 instead. In any event on the basis of Dr Dillon's evidence only the short time spent in Ward 25 on the evening of 20 June might have any causal bearing on the death.</span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>30.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>On 22nd June Danielle's clinical condition deteriorated. Blood tests found grossly abnormal serum alanine transaminase activity and prothrombin time indicating a diagnosis of acute liver failure. It was noted in Danielle's clinical records that her IV Paracetamol dosage had been too high for her weight. A diagnosis of drug-induced liver failure was considered, including possible paracetamol-induced liver failure. Ceftriaxone, clarithromycin, metronidazole, and paracetamol were discontinued, and intravenous acetylcysteine administered as an antidote for paracetamol toxicity. Danielle was discussed with the Scottish Liver Transplant Unit at the Royal Infirmary of Edinburgh and transferred there for ongoing care in the early hours of Monday 23 June. </span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>31.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Whilst at the Royal Infirmary, acetylcysteine administration and supportive measures continued, with repeated blood tests to monitor liver function. These show that the alanine transaminase activity and prothrombin time were falling, indicating that the acute liver failure was resolving rather than progressing. Danielle however suffered cardiac arrest and died at 1025 hours on </span><span lang=EN-GB style='font-size:12.0pt;
 line-height:200%;font-family:"Palatino Linotype"'>24th June 2008</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>.</span></p><p class=ListParagraphCxSpMiddle style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>32.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>Danielle's death was reported to the Procurator Fiscal by the RIE. The iatrogenic overdose of Paracetamol should have been reported by staff at the Southern General Hospital to the Health Board but was not: any member of staff could report the incident but none did. The incident did not come to the Health Board's attention until they were contacted by the Procurator Fiscal some months later. The Health Board commenced an investigation. It quickly became apparent that there was a widespread failure on the part of staff to appreciate that IV Paracetamol required to be prescribed in accordance with patient weight in those lighter than 50kg. Interim steps were taken to draw this to the attention of staff. A Significant Incident Review was issued in January 2009 [Crown Production No.5]. A Rapid Alert Notice was issued [Crown Production No.11]. The detailed steps taken were as narrated in the Review, in a subsequent Action Plan [Crown Production No.10] and in Fourth Inventory for the Health Board Production No.3. There has been a drive to try to educate staff as to the danger of mis-prescribing of Perfalgan and a dawning realisation that despite these efforts prescribing errors continued to be made. This has more recently lead to the tight restriction of the use of Perfalgan within the Medical Directorate to those patients for whom a specific case for use can be made. It is submitted that on having Danielle's death drawn to its attention the Health Board has acted with all possible despatch to avoid recurrence and, subject to considering any specific suggestions from the Crown, from the other parties, or from Your Lordship it is not obvious that there is scope for any recommendation to be made directed at further action to be taken by the Health Board. </span></p><p class=ListParagraphCxSpLast style='text-indent:-18.0pt;line-height:200%;
text-autospace:none'><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>33.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;
font-family:"Palatino Linotype"'>The Health Board has reported concerns about Perfalgan to outside bodies, including the MHRA. Problems with Perfalgan extend beyond this particular Health Board. Crown witness Dr Dillon when instructed in late 2009 found that none of the junior doctors in his unit at </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>Ninewells</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'> </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:
  "Palatino Linotype"'>Hospital</span><span lang=EN-GB style='font-size:12.0pt;
line-height:200%;font-family:"Palatino Linotype"'>, </span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'>Dundee</span><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Palatino Linotype"'> knew of the need to adjust dosage for weight. Neither did consultant colleagues to whom he spoke, apart from Anaesthetists. In his view a death similar to Danielle's could occur in his hospital. (It was not apparent whether Tayside Health Board have since taken any steps to consider whether and if so how to address this risk.) Further in July this year the MHRA issued a Drug Safety Update [Health Board 5<sup>th</sup> Inventory Production No.3] warning of accidental overdoses during treatment with Perfalgan. It is noted in the Update that Perfalgan is under intensive monitoring by the MHRA. Your Lordship may then wish to consider whether anything could be done to help bring the issues surrounding safe prescription of Perfalgan to the attention of those placed to do something about it. This would have to keep in mind the dangers of "over-reach". They might include as a minimum the sending of a copy of the Determination to the MHRA. </span></p><p class=MsoNormal><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></p><span lang=EN-GB style='font-size:12.0pt;line-height:150%;font-family:"Palatino Linotype"'><br clear=all style='page-break-before:always'></span><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Appendix to the FAI determination re Danielle Welsh </span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Appendix number 4</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Excerpt from written submissions on behalf of Dr Das and Dr Fraser</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>"Dr Fraser is a Consultant Physician with an entry on the Specialist Register for both general medicine and rheumatology, which was her position in June 2008. Dr Das was in the first year of her training, in her third medical post of that year at that time but has since moved on with her training. When she gave evidence she was what is known as ST1 in paediatrics - she told us that meant she was in the first year of her paediatric training.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>I propose to restrict my submissions to the limited, and essentially, defined involvements which both Drs Fraser and Das had with Danielle, leaving the wider issues for others to deal with. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Background narrative</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>In June 2008, Dr Fraser was a Consultant Physician with an entry in the specialist registers for both general medicine and rheumatology. She worked in the medical unit of the Southern General and dealt with inpatients in Ward 21 as well as outpatients. In Ward 21, she was one of three consultants who each had responsibility for the continuing care of patients allocated to her within that ward. Patients were allocated either on the basis of their being an elective admission for a particular consultant, or on a numerical division of incoming patients admitted through the medical receiving unit. Danielle was allocated to Dr Fraser on the latter basis, she having come in to hospital through A&amp;E and into medical receiving. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Dr Fraser first saw Danielle on the morning of 17 June and spent some time examining her. All of that was gone through in her evidence in chief, very carefully. Dr Fraser commented that she was concerned about the lack of diagnosis for Danielle and that she was keen to progress the various investigations required to come to a diagnosis. She gave evidence about her review of the kardex to check the correct drugs were being given and of the ongoing discussions with the neurologists who would be required to facilitate the </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>MRI</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> scan, and lumbar puncture which it was thought Danielle would need to diagnose any underlying condition. It was clear, in my submission, that Dr Fraser was concerned about Danielle, on that, her first full day in the ward. That concern did not abate the following day, and your lordship will recall Dr Fraser's evidence about her call to Dr Overell the consultant neurologist asking that he take over the care of Danielle to allow the various investigations to be carried out. At that point, when Danielle left ward 21 Dr Fraser was not involved further, other than, of course, in relation to the investigation which was later carried out in the hospital.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Dr Das was involved with Danielle on only one occasion. She was the junior doctor, the FY1, who was on call for the backshift which would cover eight different wards. In the period form </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>5pm</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> until </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>8pm</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> she would be the only junior doctor there, and from </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>8pm</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> a second junior doctor would also be available. It was usual for a junior doctor to be bleeped by the nursing staff if they required a doctor to do something. In this case, on arrival in the ward, Dr Das was informed that Danielle was not taking oral medication and that she required analgesia to be prescribed using an alternative route. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Your Lordship will recall that Dr Das described her on call work as being a "very busy situation when you are running from ward to ward". It was her evidence that usually when called to a ward there would be a number of kardexes left on the nursing table for the doctor to look at and deal with. It was her evidence that the kardexes would be left open at a relevant page with a "sticky note" applied to indicate what was required. The medical notes are not generally available, and in fact can be difficult to find. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Dr Das recalled that in this case, she spoke to a member of nursing staff who suggested the IV route for paracetamol as Danielle was already on other IV drugs and had the appropriate access already. It was apparent from the kardex that Danielle had already been prescribed paracetamol, and that one of the early prescriptions (of 16 June) was for the paracetamol to be given either "</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>PO</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>" (orally) or "IV" (intravenously). As a result of the request from the nurse, and of her perusal of the kardex itself, Dr Das wrote Danielle up for a prescription of paracetamol, to be given intravenously four times per day, at a dose of 1gramme. That was the only involvement Dr Das had with Danielle. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>It is my primary position that both Dr Das and Dr Fraser gave evidence clearly and straightforwardly. Neither sought to hide from their involvement in the case and Dr Das was completely frank in her admission that she did not think she required to check the prescription in the formularies, and why not. Both were credible and reliable in my submission.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Intravenous paracetamol</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Dr Das prescribed the paracetamol to be administered intravenously rather than rectally or orally. Clearly the oral route was not appropriate on 17 June due to the concerns of the nursing staff. It was they who sought an alternative prescription. Dr Das, as well as Dr Fraser, both gave evidence that in this case it would not have been appropriate for Danielle to have been given paracetamol rectally. Dr Das described it as not being the best route for a young lady, and went on to state that the route of administration is not pleasant. Dr Fraser, whilst noting that this would be a usual alternative route to that of oral analgesia did not suggest it to be appropriate in the case of Danielle.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Having made the decision to proceed with intravenous paracetamol Dr Das prescribed in a similar way to the previous, as required prescription. In particular, she prescribed it at 1gm four times per day. This is the same dose as that which would be prescribed orally for an adult or a child older than 12.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Dr Das, unlike all of the other doctors who saw Danielle after the prescription was written, did not know that Danielle was of small stature or of low weight. She did not see the patient she thought she was prescribing routine medication to. Danielle was not drawn to her attention, she did not have sight of the medical notes (where Danielle's weight was recorded), and no one flagged that Danielle was an unusual patient. Dr Das was working in a hospital with an adult population and so did not expect there would be such a small person there. She had not seen children in that post, and although she was working with the elderly had dealt with no one of low weight. Thus the issue of weight was not at the front of her mind. Her evidence was that she did not see the patient as she was told that the patient just needed the route of administration changed, but she would have seen her patient if there was a complaint of feeling unwell, or if the prescription to relieve pain had not worked. As far as she was concerned, based on the information she had it was a routine task for a junior doctor.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>It is relevant, in my submission, to note here that if Dr Das had been told that Danielle weighed only 35kgs or if that weight had been marked on the kardex, whilst she did not understand there to be any difference between oral and intravenous paracetamol her evidence was that she would have adjusted the dose. She indicated in her evidence that she had previously worked in paediatrics and there every medication is prescribed according to weight. Even if she had been prescribing oral paracetamol to a child she would have adjusted it. She had experience of doing that. . </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><i><span lang=EN-GB style='font-family:"Palatino Linotype"'>As a result of not appreciating there was a difference, she did not look it up in either the junior doctor's handbook, or in the BNF. </span></i></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Dr Fraser was also quite straightforward in confirming that as at June 2008 she had not appreciated that there was a difference in dose, potentially, between oral and IV paracetamol. The evidence shows that on 18 June Danielle was still confused and agitated (thus the move to ward 67 to allow sedation for the </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>MRI</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> and lumbar puncture) and so still in need of the intravenous paracetamol.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>None of the doctors who came to give evidence had known that there was a difference in dosage of intravenous and oral paracetamol, and Dr Dillon very fairly commented that this dreadful overdose could just as easily have occurred on his unit given that the eight junior doctors he canvassed after receiving instructions to produce his report had been unaware of this.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Perhaps more worryingly, those pharmacists from whom we heard, and who check the kardexes for errors and toxicity of drugs did not know of need to consider a difference in oral and IV administration. It became clear throughout the evidence that this was a common failing which only came to light as a result of the investigation into Danielle's death, and which investigation has resulted in audits being carried out. Those audits themselves uncovered other prescribing errors and resulted in the Rapid Alert being issued (CP 11)</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>I note that Dr Overell commented in his evidence that he felt more responsibility should ascribe to the prescribing doctor than to the reviewing doctors. It is my submission that that evidence should be disregarded. It appears that none of the clinicians involved made any effort to check the dosage, did not know that it should be altered for weight, or indeed that there was any difference between oral and intravenous and thus ignored the entry on the kardex. On this point it is notable that the kardex and the use of intravenous paracetamol ought to have been reviewed during Danielle's progress through the wards. Dr Das, in her evidence noted that intravenous paracetamol should be changed to oral paracetamol as soon as appropriate. Whilst we did not hear evidence that it was ever considered, by any clinician, it clearly did not happen, although there is evidence from Mrs Welsh that Danielle had improved greatly over her stay in hospital. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Submissions in terms of the Act</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Section 6 (1) (a)</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>It is my submission that Miss Danielle Welsh 1025 on </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>Tuesday 24 June 2008</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>, within the Royal Infirmary of Edinburgh. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>S 6 (1) (b)</span></b><span lang=EN-GB style='font-family:"Palatino Linotype"'> </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>The cause of death was as certified by Dr Julie McAdam as being 1(a) Liver failure due to 1(b) paracetamol toxicity. The evidence of Dr McAdam, along with that of Professor Burt and Dr Dillon is accepted. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>s6 (1) (c)</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>In considering reasonable precautions which may have prevented the death of Danielle, I have had regard only to those matters which relate to Dr Das, and to Dr Fraser leaving the wider picture to others. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>It is my submission that no reasonable precautions may be suggested, in connection with the evidence given by Dr Das and concerning her actions in dealing with Danielle. The nature of Dr Das' involvement makes the implementation of any recommendations around her error difficult.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>It is quite clear that the paracetamol was prescribed at a level which was too high for someone of Danielle's weight. It is equally clear, in my submission that none of the clinical staff were aware of the difference. There was complacency in dealing with an "old" drug such as paracetamol such that no one picked up on the initial prescribing error. There is no explanation for that, other than it would appear that the reviewers of the kardex were reassured at seeing paracetamol and did not question it at all. This despite those reviewers being well aware of Danielle's weight and need for adjusted antibiotics. Had any single person been aware of the difference between IV and oral paracetamol then the error, if it had been made in the first place, could have been picked up.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>It may be suggested by others that a reasonable precaution would have been for Dr Das to have checked the BNF. That is a matter for your Lordship, but in my submission, whilst all the witnesses indicated that should be done when dealing with an unfamiliar drug, I do not recall any saying that they would have done it. None has said that it was unreasonable of Dr Das not to have done it, as I recall. I repeat here that for a precaution to be reasonable there had to be evidence that a party's action or omission was not reasonable and it is my submission that the evidence does not take us that far.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Another suggestion which I am quite sure will be raised is that a doctor should see a patient before prescribing. Whilst that almost seems trite, it is relevant again to comment that no one criticised that action - indeed I don't recall any witness being asked to comment on it. Dr Das gave clear evidence that she acted as any other junior doctor on call acts, in her experience. She had too many "routine" tasks to do, to allow her to visit all patients she was asked to prescribe for and no particular reason for visiting Danielle was flagged to her.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>s6 (1) (d)</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>I do not propose to deal with systemic defects on behalf of Dr Das, or Dr Fraser, as it is my submission that both operated within the system in place as far as they were concerned. Others will comment on the systemic failures in this case.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>s6 (1) (e)</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>There are no facts to note which are relevant to the circumstances of death, and connected with Dr Das other than those noted above. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>As far as Dr Fraser is concerned, she did note that if Danielle had had a less fragmented path through her hospital stay then the error relating to the paracetamol may have been picked up earlier. It may be relevant therefore to note that a more appropriate path for Danielle to have followed would have been to send her back to Dr Fraser from Ward 67, once the neurology team had dealt with the investigations they required to assist with. This may be something which your Lordship wishes to comment on here. </span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Conclusion</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'></span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>In conclusion therefore, I invite the court to make formal findings under s6 (1) (a) and (b) of the Act, in relation to both Drs Fraser and Das, and thereafter if his Lordship considers it appropriate to make any further findings about their actions in that period in June 2008, to record those under s 6 (1) (e).</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><span lang=EN-GB style='font-size:12.0pt;line-height:150%;font-family:"Palatino Linotype"'><br clear=all style='page-break-before:always'></span><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Appendix to the FAI determination re Danielle Welsh </span></b></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>&nbsp;</span></b></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Appendix number 5</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Steps taken by the Health Board and others after the fatality; this information was spoken to by Julie McQueen</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>1.</span></b><span lang=EN-GB style='font-family:"Palatino Linotype"'> <b>Postscript Safety bulletin 4.</b></span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>"Intravenous paracetamol - raising awareness of potential safety issues specific to this product"</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>http ://www. ggcformulary. scot.nhs.uk/PS%20 Safety/PS%20Safety4.pdf</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>This was produced by Safer Use of Medicines Subcommittee of the Area Drug and Therapeutics Committee and circulated widely within NHS </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>GGC</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> to medical, pharmacy and nursing staff.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>This bulletin has also been used as the main source of information for sharing details outwith NHS </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>GGC</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> as outlined below.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>2. Postscript Acute Bulletin</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>The information contained in Postscript Safety bulletin was updated to run in a Postscript Acute bulletin which issued from the Area Drug and Therapeutics Committee in June/July 2010 and focusing on issues relevant to Acute care (all IV paracetamol use is within Acute care) .</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>This bulletin re-inforces the original safety messages and also provides updates/new information, for example new guidance on management of IV paracetamol overdose (see below)</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>3. Safer Use of Medicines Subcommittee Organisational Learning Report</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>http://wvrw.staffnet.ggc.scot.nhs.uk/CorporateTo20Services/ClinicalTo20Governance/Documents/Organisational To20learnin eTo20report-</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>7o207o20Safer7o20Use%20of o/'20Medicines7o20CommittteeZ008-09.pdf???</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>IV paracetamol safety was included in the 2008-9 annual report and will be updated in the 2009-10 annual report. This report is on the agenda of all Acute Directorate clinical governance committees.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>4. National Patient Safety Agency (</span></b><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>England</span></b><b><span lang=EN-GB style='font-family:"Palatino Linotype"'> and </span></b><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>Wales</span></b><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>) www.npsa.nhs.uk</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>The Postscript Safety bulletin was sent to the National Patient Safety Agency (which covers </span><span lang=EN-GB style='font-family:
   "Palatino Linotype"'>England</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> and </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>Wales</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>). The NPSA have data on incidents reported nationally in </span><span lang=EN-GB style='font-family:
   "Palatino Linotype"'>England</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> and </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>Wales</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> involving IV paracetamol. The NPSA have recently intimated that they are not working further on this area and that the Medicines and Healthcare Regulatory Agency are responsible for any actions in relation to IV paracetamol.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>NB There is no equivalent body to the NPSA in </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>Scotland</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> although NHS Quality</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Improvement </span><span lang=EN-GB style='font-family:
   "Palatino Linotype"'>Scotland</span><span lang=EN-GB style='font-family:
"Palatino Linotype"'> (NHS QIS) is assessing this issue</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>5. Medicines and Healthcare Regulatory Agency www'mhra.gov.uk</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Postscript Safety bulletin was sent to the MHRA.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>The MHRA are currently reviewing IV paracetamol in conjunction with other European Medicines Regulatory Agency member states (IV paracetamol licensed in </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>UK</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> through primary license in </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>France</span><span lang=EN-GB style='font-family:"Palatino Linotype"'>). The MHRA have access to the data from NPSA and we have given them a list of concerns relating to the product and potential for errors in prescribing/administration.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>The MHRA actions have not been confirmed but could include various actions such as letters to all UK-registered doctors/pharmacists, inclusion in DrugSafetyUpdatebulletin(httpJ/www.mhra.gov.ulc/Publications/SafetyguidanceiDrugSafetyUpdate/CON038625), changes to labeling and package inserts of IV paracetamol-</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>6. National Poisons Information Service www.npis.org.uk</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Postscript Safety bulletin was sent to the NPIS and information about the incident plus concerns around prescribing/administration.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>The NPIS have recently issued new guidance on rnanagement of ry paracetamol overdose to address the differences with oral paracetamol (previously only guidance specific to oral paracetamol overdose was available and advice was extrapolated from this). We are taking various actions (eg Postscript Acute bulletin) to help disseminate this information locally and we have also flagged to MHRA.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>7. Presentations to Professional groups.</span></b></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>Numerous formal and informal presentations have been delivered to raise awareness of the potential problems with IV paracetamol, including the following information </span></p><ul style='margin-top:0pt' type=disc><li class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>information on audit/re-audit work of use of IV paracetamol</span></li> <li class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>information on incidents reported</span></li> <li class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>key information/advice for safe prescribing administration</span></li></ul><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>A generic presentation and supporting data is available to all staff via the Intranet.</span></p><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p><p class=MsoNormal style='line-height:150%'><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>8. Examples within NHS </span></b><b><span lang=EN-GB style='font-family:"Palatino Linotype"'>GGC</span></b></p><ul style='margin-top:0pt' type=disc><li class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>Presentation at various 'Grand Rounds' within NHS </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>GGC</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> (includes senior and junior medical staff) and Clinical Governance meetings multidisciplinary)</span></li> <li class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>Inclusion in education sessions relating to rnedicines safety (examples: Regional Services multidisciplinary integrated training programme, Practice Development Medicines Update for nurses, pharmacy peer review rneetings)</span></li> <li class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:"Palatino Linotype"'>NHS </span><span lang=EN-GB style='font-family:"Palatino Linotype"'>GGC</span><span lang=EN-GB style='font-family:"Palatino Linotype"'> Patient Safety Conference (2010)</span></li></ul><p class=MsoNormal style='line-height:150%'><span lang=EN-GB style='font-family:
"Palatino Linotype"'>&nbsp;</span></p></div></body></html>